CELANESE CORPORATION0001306830DEF
14AFALSE00013068302022-01-012022-12-31iso4217:USDiso4217:USDxbrli:shares00013068302021-01-012021-12-3100013068302020-01-012020-12-310001306830ce:AdjustmentEquityAwardsReportedValueMemberecd:PeoMember2022-01-012022-12-310001306830ce:AdjustmentEquityAwardAdjustmentsMemberecd:PeoMember2022-01-012022-12-310001306830ce:AdjustmentEquityAwardsReportedValueMemberecd:PeoMember2021-01-012021-12-310001306830ce:AdjustmentEquityAwardAdjustmentsMemberecd:PeoMember2021-01-012021-12-310001306830ce:AdjustmentEquityAwardsReportedValueMemberecd:PeoMember2020-01-012020-12-310001306830ce:AdjustmentEquityAwardAdjustmentsMemberecd:PeoMember2020-01-012020-12-310001306830ce:EquityAwardsGrantedDuringTheYearUnvestedMemberecd:PeoMember2022-01-012022-12-310001306830ce:EquityAwardsGrantedInPriorYearsUnvestedMemberecd:PeoMember2022-01-012022-12-310001306830ecd:PeoMemberce:EquityAwardsGrantedDuringTheYearVestedMember2022-01-012022-12-310001306830ce:EquityAwardsGrantedInPriorYearsVestedMemberecd:PeoMember2022-01-012022-12-310001306830ce:EquityAwardsThatFailedToMeetVestingConditionsMemberecd:PeoMember2022-01-012022-12-310001306830ce:EquityAwardsValueOfDividendsAndOtherEarningsPaidAdjustmentMemberecd:PeoMember2022-01-012022-12-310001306830ce:EquityAwardsGrantedDuringTheYearUnvestedMemberecd:PeoMember2021-01-012021-12-310001306830ce:EquityAwardsGrantedInPriorYearsUnvestedMemberecd:PeoMember2021-01-012021-12-310001306830ecd:PeoMemberce:EquityAwardsGrantedDuringTheYearVestedMember2021-01-012021-12-310001306830ce:EquityAwardsGrantedInPriorYearsVestedMemberecd:PeoMember2021-01-012021-12-310001306830ce:EquityAwardsThatFailedToMeetVestingConditionsMemberecd:PeoMember2021-01-012021-12-310001306830ce:EquityAwardsValueOfDividendsAndOtherEarningsPaidAdjustmentMemberecd:PeoMember2021-01-012021-12-310001306830ce:EquityAwardsGrantedDuringTheYearUnvestedMemberecd:PeoMember2020-01-012020-12-310001306830ce:EquityAwardsGrantedInPriorYearsUnvestedMemberecd:PeoMember2020-01-012020-12-310001306830ecd:PeoMemberce:EquityAwardsGrantedDuringTheYearVestedMember2020-01-012020-12-310001306830ce:EquityAwardsGrantedInPriorYearsVestedMemberecd:PeoMember2020-01-012020-12-310001306830ce:EquityAwardsThatFailedToMeetVestingConditionsMemberecd:PeoMember2020-01-012020-12-310001306830ce:EquityAwardsValueOfDividendsAndOtherEarningsPaidAdjustmentMemberecd:PeoMember2020-01-012020-12-310001306830ce:AdjustmentEquityAwardsReportedValueMemberecd:NonPeoNeoMember2022-01-012022-12-310001306830ce:AdjustmentEquityAwardAdjustmentsMemberecd:NonPeoNeoMember2022-01-012022-12-310001306830ce:AdjustmentEquityAwardsReportedValueMemberecd:NonPeoNeoMember2021-01-012021-12-310001306830ce:AdjustmentEquityAwardAdjustmentsMemberecd:NonPeoNeoMember2021-01-012021-12-310001306830ce:AdjustmentEquityAwardsReportedValueMemberecd:NonPeoNeoMember2020-01-012020-12-310001306830ce:AdjustmentEquityAwardAdjustmentsMemberecd:NonPeoNeoMember2020-01-012020-12-310001306830ce:EquityAwardsGrantedDuringTheYearMemberecd:NonPeoNeoMember2022-01-012022-12-310001306830ce:EquityAwardsGrantedInPriorYearsMemberecd:NonPeoNeoMember2022-01-012022-12-310001306830ce:EquityAwardsGrantedDuringTheYearVestedMemberecd:NonPeoNeoMember2022-01-012022-12-310001306830ce:EquityAwardsGrantedInPriorYearsVestedMemberecd:NonPeoNeoMember2022-01-012022-12-310001306830ce:EquityAwardsThatFailedToMeetVestingConditionsMemberecd:NonPeoNeoMember2022-01-012022-12-310001306830ce:EquityAwardsValueOfDividendsAndOtherEarningsPaidAdjustmentMemberecd:NonPeoNeoMember2022-01-012022-12-310001306830ce:EquityAwardsGrantedDuringTheYearMemberecd:NonPeoNeoMember2021-01-012021-12-310001306830ce:EquityAwardsGrantedInPriorYearsMemberecd:NonPeoNeoMember2021-01-012021-12-310001306830ce:EquityAwardsGrantedDuringTheYearVestedMemberecd:NonPeoNeoMember2021-01-012021-12-310001306830ce:EquityAwardsGrantedInPriorYearsVestedMemberecd:NonPeoNeoMember2021-01-012021-12-310001306830ce:EquityAwardsThatFailedToMeetVestingConditionsMemberecd:NonPeoNeoMember2021-01-012021-12-310001306830ce:EquityAwardsValueOfDividendsAndOtherEarningsPaidAdjustmentMemberecd:NonPeoNeoMember2021-01-012021-12-310001306830ce:EquityAwardsGrantedDuringTheYearMemberecd:NonPeoNeoMember2020-01-012020-12-310001306830ce:EquityAwardsGrantedInPriorYearsMemberecd:NonPeoNeoMember2020-01-012020-12-310001306830ce:EquityAwardsGrantedDuringTheYearVestedMemberecd:NonPeoNeoMember2020-01-012020-12-310001306830ce:EquityAwardsGrantedInPriorYearsVestedMemberecd:NonPeoNeoMember2020-01-012020-12-310001306830ce:EquityAwardsThatFailedToMeetVestingConditionsMemberecd:NonPeoNeoMember2020-01-012020-12-310001306830ce:EquityAwardsValueOfDividendsAndOtherEarningsPaidAdjustmentMemberecd:NonPeoNeoMember2020-01-012020-12-31000130683012022-01-012022-12-31000130683022022-01-012022-12-31000130683032022-01-012022-12-31000130683042022-01-012022-12-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
(Rule 14a-101)
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the Registrant þ
Filed by a Party other than the Registrant ¨
Check the appropriate box:
¨ Preliminary
Proxy Statement
¨ Confidential,
for Use of the Commission Only (as permitted by
Rule 14a-6(e)(2))
þ
Definitive Proxy Statement
¨
Definitive Additional Materials
¨ Soliciting
Material Pursuant to §240.14a-12
|
|
|
CELANESE CORPORATION |
(Name of Registrant as Specified In Its Charter) |
(Name of Person(s) Filing Proxy Statement, if other than the
Registrant) |
Payment of Filing Fee (Check the appropriate box):
|
|
|
|
|
|
þ
|
No fee required |
|
|
¨
|
Fee paid previously with preliminary materials. |
|
|
¨
|
Fee computed on table in exhibit required by Item 25(b) per
Exchange Act Rules 14a-6(i)(1) and 0-11. |

|
|
|
|
|
|
Table of Contents |
LETTER TO SHAREHOLDERS FROM OUR CHAIR/CEO AND OUR LEAD INDEPENDENT
DIRECTOR |
|
|
|
NOTICE OF ANNUAL MEETING OF SHAREHOLDERS |
|
|
|
VOTING INFORMATION |
|
|
|
PROXY STATEMENT SUMMARY |
|
Director Nominees |
|
Director Nominee Highlights |
|
Environmental, Social and Governance Update |
|
Performance Highlights |
|
Additional Information |
|
|
|
PROXY STATEMENT |
|
Information About Solicitation and Voting |
|
|
|
GOVERNANCE |
|
ITEM 1:
ELECTION OF DIRECTORS
|
|
Director Nominees |
|
Board and Committee Governance |
|
Board Oversight |
|
Shareholder Engagement |
|
Additional Governance Matters |
|
Director Compensation |
|
Director Independence and Related Person Transactions |
|
|
|
STOCK OWNERSHIP INFORMATION |
|
Principal Shareholders and Beneficial Owners
|
|
Securities Authorized for Issuance Under Equity Compensation
Plans |
|
|
|
|
|
|
|
|
|
AUDIT MATTERS |
|
Audit Committee Report
|
|
ITEM 2:
RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM
|
|
|
|
EXECUTIVE COMPENSATION* |
|
ITEM 3:
ADVISORY APPROVAL OF EXECUTIVE COMPENSATION
|
|
ITEM 4:
ADVISORY APPROVAL OF SAY ON PAY VOTE FREQUENCY
|
|
Compensation Discussion and Analysis
|
|
Compensation Risk Assessment
|
|
Compensation and Management Development Committee
Report
|
|
Compensation Tables
|
|
CEO Pay Ratio
|
|
Pay Versus Performance |
|
|
|
MANAGEMENT PROPOSAL |
|
ITEM 5:
APPROVAL OF THE AMENDED AND RESTATED 2018 GLOBAL INCENTIVE
PLAN
|
|
|
|
QUESTIONS AND ANSWERS |
|
Annual Meeting Information
|
|
Proxy Materials and Voting Information
|
|
Company Documents, Communications and Shareholder
Proposals
|
|
|
|
EXHIBIT A |
|
Non-U.S. GAAP Financial Measures |
|
EXHIBIT B |
|
Amended and Restated 2018 Global Incentive Plan
|
|
|
|
|
|
*Detailed table of contents for compensation topics on page
50.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cautionary Note Regarding Forward-Looking Statements;
Available Information
This Proxy Statement includes estimates, projections, statements
relating to our business plans, objectives, and expected operating
results that are “forward-looking statements” within the meaning of
the Private Securities Litigation Reform Act of 1995, Section 27A
of the Securities Act of 1933, and Section 21E of the Securities
Exchange Act of 1934. Forward-looking statements may
appear throughout this Proxy Statement. These forward-looking
statements generally are identified by the words “believe,”
“project,” “expect,” “anticipate,” “estimate,” “intend,”
“strategy,” “future,” “opportunity,” “plan,” “may,” “should,”
“will,” “would,” “will be,” “will continue,” “will likely result,”
and similar expressions. Forward-looking statements are
based on current expectations and assumptions that are subject to
risks and uncertainties that may cause actual results to differ
materially. We describe risks and uncertainties that could cause
actual results and events to differ materially in “Risk Factors”
and “Management’s Discussion and Analysis of Financial Condition
and Results of Operations” sections of our
Forms 10-K and 10-Q. We undertake no obligation
to update or revise publicly any forward-looking statements,
whether because of new information, future events, or
otherwise.
References to our website in this Proxy Statement are provided as a
convenience, and the information on our website is not, and shall
not be deemed to be a part of this Proxy Statement or incorporated
into any other filings we make with the SEC. The SEC maintains a
website that contains reports, proxy and information statements,
and other information regarding issuers, including Celanese
Corporation, that electronically file with the SEC at
http://www.sec.gov.
|
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
i
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
A letter from Lori J. Ryerkerk, our Chair and CEO
and William M. Brown, our Lead Independent Director |
|
March 9, 2023
Dear Fellow Shareholders:
As the Chair and the Lead Independent Director of the Celanese
Board, we are pleased to write to you in advance of our upcoming
Annual Meeting of Shareholders. The Board is pleased with
Celanese’s performance and accomplishments in 2022 and early 2023
in the face of a number of macroeconomic and geopolitical
challenges.
Growing and Transforming Our Business
Author John Maxwell said, “Change is inevitable. Growth is
optional.” Since we wrote to you at this time last year, Celanese
has seen no shortage of change
and
growth.
Much of the change we navigated in 2022 was unfavorable to us and
many of our Fortune 500 peers: geopolitical uncertainty, supply
chain disruptions, logistics challenges, new or reinstated pandemic
lockdowns in China, waning consumer demand coupled with inflation
and recessionary trends – all impacting our business lines and
geographies.
Through it all, our team handled the adverse changes and remained
focused on our growth. Our numerous accomplishments growing and
transforming our business include:
•achieving
our second highest adjusted earnings per share in our history,
along with robust free cash flow;
•announcing
the acquisition of the majority of DuPont’s Mobility and Materials
business and closing the $11 billion deal in less than nine
months;
•achieving
full integration of our Santoprene acquisition from 2021 and
completing the restructuring of our KEPCO joint venture;
and
•expanding
capacity and achieving production records at many
facilities.
We are proud of the results the Celanese team has
achieved.
Advancing our Sustainability Strategy
Celanese is also proud of our continued progress in furthering our
sustainability strategy, described elsewhere in this Proxy
Statement.
•We
advanced our product strategy through the launch of several new
bio-based and recycled-content products.
•Following
the setting of environmental goals in early 2022, we took the
additional step of obtaining limited assurance of our environmental
target baselines and 2022 CDP Climate and Water Security responses,
to enhance the rigor of our reporting;
•We
highlighted our progress and more in our updated and redesigned
2021-2022 Sustainability Report and Index to enable efficient
access to our policies, practices, and metrics; and
•We
were recognized by Newsweek as one of America’s 500 Most
Responsible Companies; Celanese ranked 138th overall, 18th in the
Materials and Chemicals industry, and 5th in the Social
category.
Some of Celanese’s other key ESG and sustainability accomplishments
during 2022 and early 2023 are also described beginning on
page
7.
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
A letter from Lori J. Ryerkerk, our Chair and CEO
and William M. Brown, our Lead Independent Director |
|
Listening to our Shareholders and Enhancing our Board
Composition
We are committed to active engagement with our shareholders to hear
your views on how your Board can continue to serve you. The Board
receives reports on your perspectives, and you can read about key
topics our investors have expressed interest in, and the steps we
have taken aligned with shareholder feedback, in the “Shareholder
Engagement” sections within “Governance”
and “Compensation
Discussion and
Analysis.”
These efforts are overseen by a Board representing a variety of
viewpoints, experience and professional qualifications as described
in "”Item
1:
Election of
Directors —
Director
Nominees.”
The Board has added five new directors in the last five years,
including two sitting executives as independent Board members.
Three of these directors elected in the last five years are women
and two are racially diverse. The Board highly values this mix of
fresh perspectives as an effective complement to the experience and
knowledge of our longer-serving directors, is proud of its members’
diversity, and is committed to thoughtful and intentional Board
refreshment.
Looking Ahead
Looking ahead, we firmly believe that our ambitious vision of
improving the world and everyday life through our people, chemistry
and innovation will continue to guide us in choosing the right
priorities that drive growth, even in the face of ongoing
macroeconomic risks and uncertainties.
Please join our Board of Directors and executive officers on
April 20, 2023, at 1:00 p.m. Eastern time, when we hold our
Annual Meeting of Shareholders in live virtual format. Your vote is
very important, and whether or not you are able to attend the event
in real time, we encourage you submit your voting instructions by
proxy as described in this document. We look forward to your
participation.
Thank you for your continued support of Celanese.
Sincerely,
Lori J. Ryerkerk William M.
Brown
Chair, Chief Executive Officer and
President Lead Independent
Director
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notice of Annual Meeting of Shareholders |
|
CELANESE CORPORATION
222 W. Las Colinas Blvd., Suite 900N
Irving, Texas 75039
|
|
|
NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
|
|
|
|
|
|
|
|
|
|
Date and Time:
|
|
April 20, 2023, 1:00 p.m. (Eastern Daylight Saving
Time)
|
Virtual Meeting Website:
|
|
Online at www.virtualshareholdermeeting.com/CE2023
|
Items of Business:
|
|
●
To elect Jean S. Blackwell, William M. Brown, Edward G. Galante,
Kathryn M. Hill, David F. Hoffmeister,
Dr. Jay V. Ihlenfeld, Deborah J. Kissire, Michael
Koenig, Kim K.W. Rucker and Lori J. Ryerkerk to serve until the
2024 Annual Meeting of Shareholders, or until their successors are
elected and qualified or their earlier resignation;
|
|
|
●
To ratify the selection of KPMG LLP as our independent registered
public accounting firm for 2023;
|
|
|
●
To hold an advisory vote to approve executive
compensation;
|
|
|
|
|
|
●
To hold an advisory vote on the frequency of future advisory votes
approving executive compensation;
|
|
|
●
To approve the Amended and Restated 2018 Global Incentive Plan;
and
|
|
|
●
To transact such other business as may properly come before the
meeting and any adjournments and postponements thereof in
accordance with the provisions of the Company’s Seventh Amended and
Restated By-laws (the “by-laws”).
|
Record Date:
|
|
You are entitled to attend the 2023 Annual Meeting virtually and to
vote if you were a shareholder at the close of business on
February 22, 2023.
|
This year’s Annual Meeting will be held as a “virtual meeting” via
the Internet at
www.virtualshareholdermeeting.com/CE2023.
You will be able to vote and submit questions online through the
virtual meeting platform during the Annual Meeting.
To ensure that your shares are represented at the meeting, we urge
you to submit your voting instructions by proxy as promptly as
possible. You may submit your proxy via the Internet or telephone,
or, if you received paper copies of the proxy materials by mail,
you can also submit a proxy via mail by following the instructions
on the proxy card or voting instruction card. We encourage you to
submit a proxy via the Internet. It is convenient and saves us
significant postage and processing costs. You can revoke a proxy at
any time prior to its exercise at the Annual Meeting by following
the instructions in the Proxy Statement.
By Order of the Board of Directors of
Celanese Corporation
A.
Lynne Puckett
Senior Vice President, General Counsel
and Corporate Secretary
Irving, Texas
March 9, 2023
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY
MATERIALS
FOR THE ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON APRIL 20,
2023
|
The Celanese Corporation 2023 Notice of Annual Meeting and Proxy
Statement, 2022 Annual Report
and other proxy materials are available at
www.proxyvote.com.
|
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
3
|
VOTING INFORMATION
You are invited to attend the Annual Meeting to be held at
1:00 p.m. (Eastern Daylight Saving Time) on Thursday,
April 20, 2023. This year’s Annual Meeting will be held as a
“virtual meeting” via the Internet at
www.virtualshareholdermeeting.com/CE2023.
It is very important that you vote in order to play a part in the
future of the Company. Please carefully review the proxy materials
for the Annual Meeting and follow the instructions below to cast
your vote on all of the voting matters.
Who is Eligible to Vote
You are entitled to vote at the Annual Meeting if you were a
shareholder at the close of business on February 22, 2023, the
record date for the meeting. On the record date, there were
110,824,914 shares of the Company’s Common Stock issued,
outstanding and entitled to vote at the Annual Meeting. Each share
of Common Stock is entitled to one vote on each proposal to be
voted on at the meeting.
How to Vote
Even if you plan to attend the Annual Meeting, please submit your
voting instructions by proxy as soon as possible using one of the
following methods for submitting a proxy (see page
107
for additional details).
Make sure to have your proxy card, voting instruction form or
Notice of Internet Availability in hand and follow the instructions
provided. Unless those documents provide different instructions,
most of our shareholders will be able to vote in advance of the
meeting by one of the following means:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
VOTE IN ADVANCE OF THE MEETING* |
|
VOTE AT THE VIRTUAL MEETING |
|
|
|
|
|
|
|
|
|
|
via the internet |
by phone |
by mail |
by QR code |
|
|
: |
) |
* |
|
|
m |
|
Visit proxyvote.com to submit a proxy via computer or your mobile
device |
Call 1-800-690-6903 or the telephone number on your proxy card or
voting instruction form |
Sign, date and return your proxy card or voting instruction
form |
Scan this QR code to vote with your mobile device
(may require downloading of free app)
|
|
|
* You will need the 16-digit control number included on your proxy
card, voting instruction form or Notice of Internet Availability of
Proxy Materials.
If you are a shareholder who holds shares through a brokerage firm,
bank, trust or other similar organization (that is, in “street
name”), please refer to the instructions from the broker or
organization holding your shares.
If you have questions or require assistance with voting your
shares, or if you need additional copies of the proxy materials,
please contact Alliance Advisors, LLC, 200 Broadacres Drive, 3rd
Floor, Bloomfield, New Jersey 07003.
Shareholders may call toll free: (800) 574-5971.
Important Note About Meeting Admission Requirements:
If you plan to attend the virtual meeting, see the answer to
question 2 on page
105
for important details on requirements to log-in to the
meeting.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Electronic Shareholder Document Delivery
|
|
Instead of receiving future copies of annual meeting proxy
materials by mail, shareholders of record and most beneficial
owners can elect to receive an e-mail that will provide electronic
links to these documents. Opting to receive your proxy materials
online will save us the cost of producing and mailing documents and
will also give you an electronic link to the proxy voting
site.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PROXY STATEMENT SUMMARY
|
We provide below highlights of certain information in this Proxy
Statement. As this is only a summary, please refer to the complete
Proxy Statement and 2022 Annual Report before you
vote.
|
|
|
|
|
|
|
Proxy Item No. 1
Election of 10 Director Nominees
|
ü
The Board recommends a vote FOR all Director Nominees
Our Board and the Nominating and Corporate Governance Committee
believe that the ten director nominees possess the necessary
qualifications to provide effective oversight of the business and
quality advice and counsel to the Company’s
management.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Director Nominees
|
|
|
|
The following table provides summary information about each
director nominee. Each nominee is to be elected by a majority of
the votes cast.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name and Qualifications
|
Age
|
Director
Since
|
Primary Occupation /
Other Public Company Boards
|
Independent
|
Committee
Memberships
|
|
|
|
|
|
|
|
|
|
|
Jean S. Blackwell |
68 |
2014 |
Former EVP / CFO – Cummins Inc. |
ü
|
AC; NCG |
|
|
&Q5ÐGq@6L
|
|
|
Ingevity Corp.; Johnson Controls Int’l plc |
|
|
|
|
William M. Brown |
60 |
2015 |
Former Executive Chair and CEO – L3Harris Technologies,
Inc. |
ü
|
CMD; NCGt
|
|
|
&Q:5Gq@6L
|
|
|
Becton, Dickinson and Company |
|
|
|
|
Edward G. Galante |
72 |
2013 |
Former SVP – Exxon Mobil Corporation |
ü
|
CMD£;
EHS
|
|
|
&Q.:ÐGq@6L
|
|
|
Linde plc; Clean Harbors Inc.; Marathon Petroleum Corp. |
|
|
|
|
Kathryn M. Hill |
66 |
2015 |
Former SVP Dev. Strategy – Cisco Systems Inc. |
ü
|
CMD; EHS£
|
|
|
&Q:5@6
|
|
|
Moody’s Corporation; NetApp Inc. |
|
|
|
|
David F. Hoffmeister |
68 |
2006 |
Former SVP / CFO – Life Technologies Corp. |
ü
|
AC; NCG |
|
|
&Q.:Gq6L
|
|
|
Glaukos Corporation; ICU Medical Inc.; StepStone Group
Inc. |
|
|
|
|
Dr. Jay V. Ihlenfeld |
71 |
2012 |
Former SVP, Asia Pacific – 3M Company |
ü
|
CMD; EHS |
|
|
Q.:5ÐG@6
|
|
|
Ashland, Inc. |
|
|
|
|
Deborah J. Kissire |
65 |
2020 |
Former Vice Chair - Ernst & Young LLP |
ü |
AC£;
EHS
|
|
|
&Q:5Gq6L
|
|
|
Omnicom Group; Axalta Coatings System Ltd.; Cable One,
Inc. |
|
|
|
|
Michael Koenig |
59 |
2022 |
Chief Executive Officer – Nobian Industrial Chemicals
B.V. |
ü
|
CMD; EHS |
|
|
&Q.:5ÐG@6L
|
|
|
Symrise AG |
|
|
|
|
Kim K.W. Rucker |
56 |
2018 |
Former EVP and GC – Andeavor |
ü
|
AC; NCG£
|
|
|
&Q:5ÐGq6L
|
|
|
Lennox International Inc.; Marathon Petroleum Corp.; HP
Inc. |
|
|
|
|
Lori J. Ryerkerk |
60 |
2019 |
Chair, Chief Executive Officer and President – Celanese
Corporation |
|
– |
|
|
&Q.:ÐGq@6L
|
|
|
Eaton Corporation plc |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Qualifications: |
|
|
|
|
|
|
|
Board Committees: |
|
|
|
|
|
|
& |
Leadership |
|
G |
Govt/regulatory |
|
AC |
Audit Committee |
|
|
|
Q |
Global experience |
|
q |
Financial & transactions |
|
CMD |
Compensation and Management Development Committee |
|
|
|
. |
Chemical industry |
|
@ |
Operational |
|
EHS |
Environmental, Health, Safety, Quality and Public Policy
Committee |
|
: |
Innovation-focused |
|
6 |
Strategic |
|
NCG |
Nominating and Corporate Governance Committee |
|
|
|
5 |
Customer-focused |
|
L |
Risk oversight |
|
£ |
Committee Chair |
|
|
|
Ð
|
Environmental / sustainability |
|
|
|
t |
Lead Independent Director |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Director Nominee Highlights
|
|
|
|
|
|
|
|
Director succession is a robust, ongoing process at Celanese. Our
Board regularly evaluates desired attributes in light of the
Company’s strategy and evolving needs. We believe that our director
nominees bring a well-rounded variety of skills, qualifications,
experience and diversity, and represent an effective mix of deep
company knowledge and fresh perspectives.
|
|
|
|
|
|
|
|
|
|
|
|
Diversity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tenure
|
|
|
|
|
Age
|
|
|
|
Expertise and Independence
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average Tenure: 7 years
|
|
Average Age: 64.5 years |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balanced Mix of Skills, Qualifications and Experience |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Environmental, Social and Governance Update |
|
|
|
|
|
Accelerating safe and sustainable solutions through
chemistry. |
|
|
|
|
|
We believe we have a responsibility to meaningfully improve the
world through the power of chemistry.
|
|
|
|
|
|
This responsibility to do more is instilled within us at Celanese,
and we believe that when chemistry connects with sustainability,
the possibilities are endless.
|
|
Sustainability Strategy Framework Under Each Segment
Celanese is committed to protecting natural resources and helping
our partners and their customers to do the same. Our three-part
sustainability strategy of building solutions to support customers’
sustainability objectives, reducing GHG emissions in our own
operations, and improving the sustainability of existing products
enables us to act on this commitment in both our Acetyl Chain and
Engineered Materials segments.
|
|
|
|
|
|
Acetyl Chain |
Engineered Materials |
|
|
•Progress
on several capital projects in Clear Lake, Texas to
◦increase
renewable energy use
and
◦turn
industrial CO2 emissions into methanol
via our Fairway Joint Venture with a projected start-up in late
2023
•Continue
to leverage energy efficiency initiatives, such as our
power and heat project
at our Lanaken, Belgium site, focused on
reducing steam usage,
and considering
limited carbon offsets
through high-quality compensation measures as a carbon-footprint
reduction tool
•Announced
availability of
more sustainable versions of several Acetyl Chain products
and
expanded the ECO-B designation
to these offerings
|
•Producing
recycled content
(designated as ECO-R) and
mass balance biocontent
(designated as ECO-B) to help customers incorporate renewable and
recycled content into their products
•Opened
a
new GUR ultra-high molecular weight polyethylene production
line at our Bishop, Texas, manufacturing facility to support the
increased demand for electric vehicles and lithium-ion battery
separator supply
•Acquired
a majority of DuPont’s Mobility & Materials
business,
which offers complementary products in high-value,
sustainability-related applications, such as materials for electric
vehicles
|
Setting Meaningful Environmental Goals
As part of our efforts to reduce our environmental impact, we have
set the below production intensity targets, which are measured
against a 2021 baseline of Celanese owned and operated assets. In
2022, we engaged ERM Certification and Verification Services, Inc.
to provide a limited assurance of our environmental baseline
metrics associated with our 2030 environmental targets — including
our target, announced in March 2022, for a 30% reduction in Scope 1
and 2 GHG Intensity (measured by product volume) by 2030 — and our
2022 CDP Climate and Water Security responses.
[1]
Based on production from a 2021 baseline.
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
7
|
Setting intensity-based targets allows us to better reflect the
effects of future organic and acquisition opportunities in
alignment with our low-carbon transition plan. In the short term,
we are looking to enhance efficiency through capital investment
projects and increase renewable energy consumption. We intend to
explore the application of power-to-steam technology, renewable
fuels, and breakthrough technologies like carbon capture and
hydrogen. We are also working to better understand our Scope 3
emissions sources to develop a roadmap to identify, quantify and
reduce them.
Reporting and Transparency
Our second Sustainability Report, published in 2022 and available
at https://sustainability.celanese.com/, highlights our recent
progress and advancements against our strategy. The accompanying
Index, also available at https://sustainability.celanese.com/,
includes a Sustainability Accounting Standards Board Index for the
Chemical Industry, Task Force on Climate-Related Financial
Disclosures Index, Human Capital and Safety Metrics, and ERM CVS
limited external assurance statements, along with policies and
other program disclosures. The information is organized by each of
our four sustainability pillars: Customer Solutions, Preserving the
Environment, People and Communities, and Operating Ethically. While
we are not including Mobility and Materials environmental data in
our reporting at this time, we hope to include this data in the
future.
Significant Achievements and Growing Momentum
Through our dedication to improve the world, we have built on our
past accomplishments and demonstrated our deep sense of
responsibility to keep people safe and help to protect our
planet:
■Received
the
U.S. Environmental Protection Agency ENERGY STAR® Award 2022
Partner of the Year
designation for the seventh consecutive year and the
Sustained Excellence designation,
the highest honor of the ENERGY STAR Awards, for the fifth
consecutive year.
■Named
to
Newsweek’s 2023 list of America’s Most Responsible
Companies
■Received
a
grant from the Bill and Melinda Gates Foundation
to produce a prototype for a refillable contraceptive implant using
our VitalDose drug delivery platform, which could expand global
access to women's health solutions in low-middle income
communities
■Improved
the Company’s
CDP Climate Score Report to “B”
■Winner
of
D CEO’s 2023 Innovation in Manufacturing and Consumer Goods
award
■Three
M&M products (Zytel® PA612, Crastin® PBT and Vamac® AEM)
won awards at the 51st Annual Society of Plastics Engineers
Automotive Innovation Awards Competition and Gala
in November 2022
■Multiple
Celanese employees
won awards at the American Chemistry Council's 2022 Annual
Responsible Care® & Sustainability Conference
in areas of environmental, health and safety
excellence
■Named
a
Top Noteworthy Company on DiversityInc’s Top 50 list
for second year
■Ranked
among best employers in Germany
through a joint survey conducted by Stern magazine and independent
opinion research institute Statista
■Engaged
ERM Certification and Verification Services, Inc.
to provide a limited assurance of our environmental baseline
metrics associated with our 2030 environmental targets and our 2022
CDP Climate and Water Security responses (available at
https://sustainability.celanese.com/reporting)
See “Human
Capital Management”
beginning on page
56
of this Proxy Statement for additional information about our human
capital efforts.
Go to https://www.celanese.com/sustainability/ to learn more about
Sustainability at Celanese.
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate Governance Highlights
|
|
|
|
Our Corporate Governance Policies Reflect Best
Practices |
|
|
|
We are committed to good corporate governance, which promotes the
long-term interests of shareholders, strengthens Board and
management accountability and helps to build public trust in the
Company. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Independent
Oversight
|
● 9 of 10 director nominees are independent (all except for the
CEO)
● Lead Independent Director with clearly defined and robust
responsibilities
● Regular executive sessions of independent directors at Board
meetings (chaired by the Lead Independent Director) and Committee
meetings (chaired by independent Committee chairs)
● 100% independent Board Committees
● Active Board oversight of the Company’s strategy, risk management
and ESG efforts
|
|
|
|
|
|
|
|
|
|
|
|
Board
Refreshment
|
● Comprehensive, ongoing Board succession planning
process
● Focus on diversity (3 of the Board’s 4 committees are chaired by
women, who are also independent directors); 5 of 10 director
nominees are women, or racially or ethnically diverse)
● Regular Board refreshment and mix of tenure of directors (10 new
directors since the beginning of 2012, 7 since the beginning of
2015, 5 since the beginning of 2018 and 2 since the beginning of
2022)
● Annual Board and Committee assessments including performance
evaluation of individual directors
● Retirement age of 75
|
|
|
|
|
|
|
|
|
Shareholder
Rights
|
● Annual election of all directors
● Majority-vote and director resignation policy for directors in
uncontested elections
● Proxy access right for shareholders (3% ownership threshold
continuously for 3 years / 2 director nominees or 20% of the Board
/ 20 shareholder aggregation limit)
● Directors may be removed with or without cause
● One class of outstanding shares with each share entitled to one
vote
● No poison pill
|
|
|
|
|
|
|
|
|
Good Governance
Practices
|
● Prohibition on hedging or pledging Company stock
● Comprehensive clawback policy
● Rigorous director and executive stock ownership
requirements
● Active shareholder engagement program
● Global Code of Conduct applicable to directors and all employees
with annual compliance certification
● Political activities disclosures on our website
● Longstanding commitment to corporate responsibility
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proxy Item No. 2
Ratify the appointment of KPMG LLP as our independent registered
public accounting firm for fiscal year ending December 31,
2023
|
ü
The Board recommends a vote FOR this proposal
The Audit Committee and the Board believe that the continued
retention of KPMG LLP to serve as the Company’s independent
registered public accounting firm for the fiscal year ending
December 31, 2023 is in the best interests of the Company and
its shareholders. As a matter of good corporate governance,
shareholders are being asked to ratify the Audit Committee’s
selection of the independent registered public accounting firm for
2023.
à
See
“Audit
Matters”
beginning on page
47
of this Proxy Statement for additional information.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Performance Highlights
|
|
|
Business Performance in 2022
(see page
53
for more information on our controllable actions to drive
performance)
|
|
|
|
ü |
We reported 2022 net sales of $9.7 billion, 13% higher than our
previous record in 2021.
|
|
|
|
ü |
We generated record operating cash flow of $1,819 million and free
cash flow(1)
of $1,263 million, supporting our deleveraging
strategy.
|
|
|
|
ü
|
Record net sales overall, record adjusted EBIT from Engineered
Materials (even excluding the Santoprene and M&M acquisitions)
and strong performance from the Acetyl Chain supported: |
|
|
|
|
t |
GAAP diluted earnings per share of $17.41, and second-highest
Adjusted EPS(1)
of $15.88; and
|
|
|
|
|
t |
Net earnings of $1,894 million and Adjusted
EBIT(1)
of $2,171 million.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Strengthening our Foundation for Earnings Per Share Growth and
Long-Term Shareholder Value |
|
|
|
ü |
In November 2022, we
closed the acquisition of the majority of the Mobility &
Materials business of DuPont (the M&M
Acquisition).
We signed and closed the $11.0 billion transaction in less than
nine months, to establish Celanese as the pre-eminent global
specialty materials company, with a broad and expanded portfolio of
engineered thermoplastics and elastomers, industry-renowned brands
and intellectual property, global production assets, and a
world-class organization.
|
|
Net Sales ($Bn) |
|
|
|
|
|
|
|
|
ü |
We also enhanced our Engineered Materials business by
completing the integration
of the Santoprene acquisition (closed December 2021) less than a
year after closing and
completing the restructuring of our KEPCO joint venture
to have more commercial control over our earnings.
|
|
|
|
|
ü |
We initiated and completed a
strategic overhaul of the acetate flake and tow products as part of
the Acetyl Chain
(AC) to deliver future earnings growth.
|
|
|
|
|
ü |
We navigated continued sourcing and logistics constraints
and
maintained margin through deliberate commercial and pricing
actions.
|
|
Earnings |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP EPS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted EPS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proxy Item No. 3
Advisory Approval of Executive Compensation
|
ü
The Board recommends a vote FOR this proposal
Our Board recommends that shareholders vote “FOR” the advisory
approval of the compensation of our named executive officers
(“NEOs” or “named executive officers”) for the 2022 performance
year.
|
|
|
|
|
|
Additional Information
|
|
|
|
Please see “Questions
and Answers”
beginning on page
105
for important information about the proxy materials, voting, the
Annual Meeting, Company documents, communications and the deadlines
to submit shareholder proposals for the 2023 Annual
Meeting.
|
|
|
|
(1)
Adjusted earnings per share, adjusted EBIT and free cash flow are
non-U.S. GAAP financial measures. See “Exhibit
A”
for information concerning these measures including a definition
and a reconciliation to the most comparable U.S. GAAP financial
measure.
|
|
|
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
10
|
PROXY STATEMENT
For the Annual Meeting of Shareholders To Be Held Virtually on
April 20, 2023
The Board of Directors (the “Board of Directors” or the “Board”) of
Celanese Corporation, a Delaware corporation (the “Company,” “we,”
“us” or “our”), solicits the enclosed proxy for use at our 2023
Annual Meeting of Shareholders (the “Annual Meeting”) to be held
virtually at 1:00 p.m. (Eastern Daylight Saving Time) on
Thursday, April 20, 2023, at our virtual meeting website
www.virtualshareholdermeeting.com/CE2023. This Proxy Statement
(this “Proxy Statement”) contains information about the matters to
be voted on at the meeting and the voting process, as well as
information about our directors. We will bear the expense of
soliciting the proxies for the Annual Meeting.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY
MATERIALS
FOR THE ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON APRIL 20,
2023
|
The Celanese Corporation 2023 Notice of Annual Meeting and Proxy
Statement, 2022 Annual Report
and other proxy materials are available at
www.proxyvote.com.
|
INFORMATION ABOUT SOLICITATION AND VOTING
Pursuant to U.S. Securities and Exchange Commission (“SEC”)
rules, we have elected to furnish proxy materials to our
shareholders via the Internet instead of mailing printed copies of
those materials to each shareholder. If you received a Notice of
Internet Availability of Proxy Materials (“Notice of Internet
Availability”) by mail, you will not receive a printed copy of the
proxy materials unless you request one. Instead, the Notice of
Internet Availability will instruct you as to how you may access
and review the proxy materials and cast your vote on the Internet.
If you received a Notice of Internet Availability by mail and would
like to receive a printed copy of our proxy materials, please
follow the instructions included in the Notice of Internet
Availability. Shareholders who requested paper copies of proxy
materials or previously elected to receive proxy materials
electronically will not receive the Notice of Internet Availability
and, instead, will receive the proxy materials in the format
requested. This Proxy Statement, our 2022 Annual Report and other
information about the Annual Meeting also are available in the
“News & Events” section of our website,
https://investors.celanese.com.
The Notice of Internet Availability and, for shareholders who
previously requested electronic or paper delivery, the proxy
materials will be mailed on March 9, 2023, to shareholders of
record and beneficial owners who owned shares of the Company’s
Common Stock at the close of business on February 22,
2023.
Our principal executive offices are located at 222 W. Las Colinas
Blvd., Suite 900N, Irving, Texas 75039.
For additional information about the proxy materials and the Annual
Meeting, see
“Questions
and Answers”.
GOVERNANCE
The Company is committed to effective corporate governance, which
promotes the long-term interests of shareholders, strengthens Board
and management accountability and helps build public trust in the
Company. See
“Corporate
Governance Highlights”
for more information.
The Company’s certificate of incorporation, by-laws, corporate
governance guidelines, Board committee charters and other materials
can be accessed on our website, https://investors.celanese.com, by
clicking “Corporate Governance.” Instructions on how to obtain
copies of these materials are also included in the response to
question 20 in the Questions and Answers section on page
110.
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
11
|
ITEM 1:
Election of Directors
Background
Based on the recommendation of our independent Nominating and
Corporate Governance Committee (the “NCG Committee”), our Board of
Directors has nominated ten directors — Jean S. Blackwell, William
M. Brown, Edward G. Galante, Kathryn M. Hill, David F.
Hoffmeister, Dr. Jay V. Ihlenfeld, Deborah J. Kissire, Michael
Koenig, Kim K.W. Rucker and Lori J. Ryerkerk — to serve a one-year
term expiring at the 2024 Annual Meeting of Shareholders.
Independent director Rahul Ghai, who joined the Celanese Board in
February 2022 and joined GE Aerospace as Chief Financial Officer in
August 2022, has decided in consultation with the rest of the NCG
Committee and the Board that he will not stand for re-election at
the upcoming Annual Meeting. Mr. Ghai has advised the Board that
his responsibilities preparing GE Aerospace to become a standalone
independent public company would make it difficult for him to
continue to have sufficient time available for Celanese Board and
committee meetings and consultation on Celanese matters as GE
Aerospace gets closer its early 2024 separation date. There is no
disagreement between Mr. Ghai and Celanese on any matter related to
Celanese’s operations, policies, or practices. The Board expresses
its thanks to Mr. Ghai for his contributions during his service,
wishes him well at GE Aerospace, and will set the number of
directors at ten effective as of the Annual Meeting.
At the Annual Meeting, shareholders will have the opportunity to
elect these nominees. Unless otherwise instructed, the proxy
holders will vote the proxies received by them “for’ these ten
nominees. If any of our nominees is unable or declines to serve as
a director as of the time of the Annual Meeting, the Board may
designate a substitute nominee or reduce the size of the Board.
Proxies will be voted for any nominee who shall be designated by
the Board of Directors to fill the vacancy. These director nominees
have consented to be elected to serve as directors for the next
year and we have no reason to believe that any of the nominees will
be unwilling or unable to serve if elected as a
director.
The name of each of our nominees for election and certain
information about them, as of the date of this Proxy Statement
(except ages, which are as of the date of the Annual Meeting), is
set forth below under “Director
Nominees,”
including the particular qualifications, attributes, skills and
experience that led the Board to conclude that each should serve as
a director of the Company.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Board Composition and Refreshment
|
|
|
BOARD REFRESHMENT
|
|
|
|
|
|
Over the last five years, we have: |
|
The Board and the NCG Committee believe the Board should represent
a collection of talented, highly-experienced, high-integrity,
strategic leaders from a variety of backgrounds with diverse
viewpoints, possessing skill sets and experience that bring value
to Celanese’s long-term strategy. To that end, the Board and NCG
Committee continuously strive to maintain, through thoughtful Board
refreshment, an appropriate balance of skills, tenure, and
diversity. The Board believes that new perspectives and new ideas
are critical to a forward-looking and strategic board, as is the
ability to benefit from the valuable experience and familiarity
with the complexities of our business that longer-serving directors
bring. The Board and the NCG Committee regularly evaluate the
skills represented on the Board, to support a thoughtful, long-term
approach towards optimizing Board composition.
|
|
|
|
|
|
●
|
Elected five new directors, three of whom are women and two of whom
are racially or ethnically diverse
|
|
|
|
●
|
Completed a Board leadership transition, and elected a new Lead
Independent Director
|
|
|
|
●
|
Rotated all Board committee chairs
|
|
|
|
●
|
Added increased industry and M&A experience while increasing
the diversity of the Board
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Our
Board has identified and elected several new directors in the last
five years as part of its strategic approach to refreshment and
succession planning:
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
12
|
•Our
Chair and CEO Ms. Ryerkerk – joined as CEO effective May 2019, and
named Board Chair in April 2020;
•Our
NCG Committee Chair Ms. Rucker – elected to the Board in October
2018;
•Our
Audit Committee Chair Ms. Kissire – elected to the Board in October
2020;
•Mr.
Ghai – elected to the Board in February 2022 (and who is not
seeking re-election for the reasons described above);
and
•Mr.
Koenig – elected to the Board in February 2022.
Each of these directors, as were all of our Board members, were
identified in large part due to the fit of their deep experience
with different aspects of our long-term strategy. See
“Director
Nominees”
for more information on the specific qualifications and experience
each of our nominees brings to our Board.
Qualifications, Qualities, Skills and Experience to be Represented
on the Board
The Board and the NCG Committee require that each director be a
recognized person of high integrity with a proven record of success
in his or her field and have the ability to devote the time and
effort necessary to fulfill his or her responsibilities to the
Company. Each director must demonstrate innovative thinking,
familiarity with and respect for corporate governance requirements
and practices, a willingness to assume fiduciary responsibilities,
an appreciation of diversity and a commitment to sustainability and
to dealing responsibly with social issues. The NCG Committee uses a
variety of methods for identifying and evaluating director nominees
and considers candidates who are recommended by Board members, by
shareholders, as well as those identified by third-party search
firms retained from time to time (including during part of 2022).
The NCG Committee and other Board members conduct interviews of
potential director candidates to assess integral qualities,
including the individual’s ability to ask difficult questions and,
simultaneously, to work collegially.
The Board considers diversity of race, ethnicity, gender, age,
cultural background and professional experience in evaluating
candidates for Board membership and assesses the effectiveness of
this policy through the NCG Committee’s annual review of director
nominees. The Board believes that diversity results in a variety of
points of view and, consequently, a more effective decision-making
process. Of the five new directors added in the last five years,
three are women and two are racially/ethnically
diverse.
The Board has identified particular qualifications, attributes,
skills and experience that are important to be represented on the
Board as a whole, in light of the Company’s current and expected
future business needs. These are summarized in the following
table.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Qualifications, Attributes, Skills
and Experience |
|
Characteristics |
No. of Directors |
&
|
Relevant senior leadership/C-Suite experience
|
|
Senior leadership experience allows directors to better understand
day-to-day and strategic aspects of a business
|
9 |
Q
|
Global business experience
|
|
Our business is global and multicultural, with products
manufactured in the Americas, Europe and Asia and operations in 18
countries around the world
|
10 |
.
|
Extensive knowledge of the Company’s business and/or chemical
industry
|
|
A deep understanding of the Company’s business and/or the chemical
industry allows a director to better guide the Company
|
5 |
:
|
Experience in innovation-focused businesses
|
|
Focus on innovation to drive performance
|
9 |
5 |
Experience in customer-driven businesses
|
|
High level of customer interaction
|
7 |
Ð
|
Environmental/sustainability experience |
|
Experience with complex environmental regulation and
sustainability-focused strategy
|
6 |
G
|
Government/regulatory/geopolitical exposure
|
|
Experience with regulatory obligations and political challenges in
various jurisdictions
|
9 |
q
|
Financial & transactions experience
|
|
High level of familiarity with financial matters and complex
financial transactions, including in foreign countries /
currencies
|
7 |
@
|
Operational experience
|
|
Experience managing manufacturing of many types and kinds of
products consistent with high level specifications and in large
quantities
|
7 |
6 |
Strategy development experience
|
|
Experience with strategy development, allowing the Board to better
evaluate management’s plan and guide the Company
|
10 |
L
|
Risk oversight/management experience
|
|
Assessment of risk and the policies/procedures to manage
risk
|
8 |
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
13
|
Director Nominees
|
|
|
|
|
|
|
|
|
|
|
|
Lori J. Ryerkerk |
|
|
|
Experience
•Chief
Executive Officer and President, Celanese (2019 – present); Chair
(2020 – present)
•Executive
Vice President of Global Manufacturing of Shell Downstream Inc.,
the largest business of Royal Dutch Shell plc (now Shell plc), a
global group of energy and petrochemical companies, where she led a
team of 30,000 employees and contractors at refineries and chemical
sites worldwide (2013 – 2018), Regional Vice President of
Manufacturing in Europe and Africa responsible for the operation of
five Shell Manufacturing facilities and five joint ventures (2010 –
2013)
•Senior
Vice President, Refining, Supply and Terminals at Hess Corporation,
where she was responsible for refineries, terminals and a
distribution network, and supply and trading (2008 –
2010)
•Multiple
operational and senior leadership roles in Refining and Chemicals
Manufacturing, Power Generation, and various other groups including
Supply, Economics and Planning, HSSE, and Public Affairs/Government
Relations at ExxonMobil (1984 – 2008)
•Former
Independent Director at Axalta Coating Systems, a leading provider
of liquid and powder coatings (2015 – 2019)
Other Current Public Company Directorships
•Independent
Director at Eaton Corporation plc, a diversified power management
company (2020 – present)
Notable Affiliations
•Board
member, American Chemistry Council (2019 – present)
•Board
member, National Association of Manufacturers (2019 –
present)
Qualifications Provided to Our Board
•Proven
experience in P&L improvement, operational excellence and value
creation in large, complex manufacturing organizations
internationally and in the U.S., leading thousands of employees and
multibillion dollar budgets at Shell, Hess and
ExxonMobil
•Leadership
of multiple nine- and ten-figure acquisitions and divestitures to
optimize manufacturing and operational portfolios
•Significant
experience in environmental and sustainability matters in the
manufacturing and energy industries, including publication of
Exxon’s first corporate-wide environmental, health and safety
report, key involvement in the American Petroleum Institute’s
establishment of guidelines for the calculation of greenhouse gas
emissions, bringing keen insight to Celanese as we design, set and
operationalize our sustainability targets and
priorities
•In
multiple roles throughout her career, led multi-year improvements
and safety and environmental metrics from individual manufacturing
sites to large global businesses
•Long
history of effectively and influentially representing her companies
and industries through trade associations and governmental
committees in both the U.S. and abroad, including experience as the
head of government relations and public affairs for the world’s
largest energy company and broad experience in trade association
leadership
•External
recognition includes being named as one of America’s Most Powerful
Women in Business by Fortune, CEO of the Year by D (Dallas)
Magazine (2020) and a member of the Department of Chemical and
Biological Engineering Hall of Fame at Iowa State University
(2021)
Education
•B.S.
in chemical engineering, Iowa State University
|
|
|
Director since:
2019
Age:
60
Current Board Committees:
None
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
14
|
|
|
|
|
|
|
|
|
|
|
|
|
Jean S. Blackwell |
|
|
|
Experience
•Chief
Executive Officer of Cummins Foundation and Executive Vice
President, Corporate Responsibility, of Cummins Inc., a leading
global designer, manufacturer, distributor and servicer of engines
and engine-related products (2008 – 2013), after serving as
Executive Vice President and Chief Financial Officer (2003 – 2008);
Vice President, Cummins Business Services (2001 – 2003); Vice
President, Human Resources (1998 – 2001); and Vice President and
General Counsel (1997 – 1998)
•Partner
at the Indianapolis law firm of Bose McKinney & Evans LLP,
where she practiced in the areas of financial and real estate
transactions (1984 – 1991)
•State
of Indiana Budget Director (1993-1995)
•Executive
Director of the Indiana State Lottery Commission
(1991-1992)
•Former
Independent Director, Essendant Inc. (formerly United Stationers
Inc.), a leading national wholesale distributor of business
products (2007 – 2018)
•Former
Independent Director, Phoenix Companies Inc., a life insurance
company (2004 – 2009)
Other Current Public Company Directorships
•Independent
Chair of Ingevity Corporation, a leading global manufacturer of
specialty chemicals and high performance carbon materials (2016 –
present)
•Independent
Director, Johnson Controls International plc, a leading diversified
technology company (2018 – present)
Notable Affiliations
•Director,
Building Tomorrow
Qualifications Provided to Our Board
•Chief
financial officer and public company audit committee chair service
at large and prominent public companies, which brings to the Board
a valuable perspective on financial, accounting, capital structure
and risk management matters
•Deep
insight into navigating an increasingly complex global regulatory
environment from experience gained as a general counsel, law firm
partner and state government leader
•Leadership
in incorporating ESG priorities into our business strategy,
leveraging experience gained as EVP of Corporate Responsibility for
Cummins, as head of HR at Cummins, as board chair of a leading
publicly-traded specialty chemical and performance materials
company and as chair of the governance and sustainability committee
of a large-cap multinational diversified technology
company
Education
•B.A.
in economics, The College of William and Mary
• University
of Michigan
|
|
|
Director since:
2014
Age:
68
Current Board Committees:
Audit
Nominating and Corporate Governance
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
15
|
|
|
|
|
|
|
|
|
|
|
|
|
William M. Brown |
|
|
|
Experience
•Executive
Chair of the Board (2021 – 2022) and Chair and Chief Executive
Officer (2019 – 2021) of L3Harris Technologies, Inc., successor to
Harris Corporation, a global aerospace and defense technology
company; President and Chief Executive Officer (2011 – 2019) and
Chair (2014 – 2019), Harris Corporation
•Various
roles at United Technologies Corporation (UTC) (1997 – 2011),
including as Senior Vice President, Corporate Strategy and
Development (2011), President of UTC’s Fire & Security Division
(2006 – 2011), additional U.S. and international roles at various
divisions including Carrier Corporation’s Asia Pacific Operations
and the Carrier Transicold division
•Senior
Engagement Manager McKinsey & Company
•Project
Engineer, Air Products and Chemicals, Inc.
Other Current Public Company Directorships
•Independent
Director at Becton, Dickinson and Company, a global medical
technology company (2022 – present)
Notable Affiliations
•Director,
Fire Department of NYC Foundation
Qualifications Provided to Our Board
•Proven
experience in the commercial, financial and cultural aspects of
large M&A execution and integration, demonstrated through
leading the $40 billion merger creating L3Harris, as well as
M&A experience as SVP of Corporate Strategy and Development at
United Technologies Corporation
•Demonstrated
leadership of complex global organizations, including his most
recent executive role as Executive Chair and CEO of L3Harris, a
global company with approximately $18 billion in revenue, 47,000
employees and customers in over 100 countries, following eight
years as CEO of Harris Corporation
•Insight
into current cybersecurity issues globally through expertise in the
defense industry as well as past service on the National Security
Telecommunications Advisory Committee
Education
•B.S.,M.S.
in mechanical engineering, Villanova University
•MBA,
The Wharton School, University of Pennsylvania
|
|
|
Director since:
2015
Age:
60
Current Board Committees:
Compensation
Nominating and Corporate Governance
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
16
|
|
|
|
|
|
|
|
|
|
|
|
|
Edward G. Galante |
|
|
|
Experience
•Senior
Vice President and Member of the management committee of Exxon
Mobil Corporation, an international oil and gas company (2001 –
2006), Executive Vice President of ExxonMobil Chemical Company
(1999 – 2001) and various management positions of increasing
responsibility over more than 30 years with the
company.
•Former
Independent Director at Foster Wheeler AG, global engineering
conglomerate (2007 – 2018)
Other Current Public Company Directorships
•Independent
Director at Linde plc, a leading industrial gas and engineering
company (2018 – present), previously Independent Director with
Praxair, Inc., an industrial gas company (2007 – 2018) prior to its
combination with Linde
•Independent
Director at Clean Harbors, Inc., a leading provider of
environmental and industrial services (2007 – present)
•Independent
Director at Marathon Petroleum Corporation, a leading, integrated,
downstream energy company (2018 – present), previously Independent
Director at Andeavor Corporation, a highly integrated marketing,
logistics and refining company acquired by Marathon (2016 –
2018)
Notable Affiliations
•LSU
Foundation
•Board
of United Way Foundation of Metropolitan Dallas
•Board
of Trustees of Northeastern University
•Director,
Artis-Naples
Qualifications Provided to Our Board
•Decades-long
operational and commercial experience in the petroleum and chemical
manufacturing industry, including as EVP of one of the largest
chemical companies in the world (Exxon Mobil Chemical), giving the
Board and executive leadership valuable long-term insight into
industry and commercial prospects, and capital deployment
optimization
•Brings
to the Board and the EHSQPP Committee significant experience in
environmental, health and safety (EHS) issues, gained from leading
Exxon Mobil's EHS activities, chairmanship of the EHS Committee of
Clean Harbors, membership on Marathon Petroleum’s Sustainability
Committee and membership on the Environmental, Health, Safety and
Security committee at Andeavor
•Chair
leadership and member service on large-company compensation
committees gives our CMDC a valuable cross-industry perspective
into best practices in driving value-creating behavior of
leadership teams in large organizations
Education
•B.S.
in civil engineering, Northeastern University
|
|
|
Director since:
2013
Age: 72
Current Board Committees:
Compensation
Environmental, Health, Safety, Quality & Public
Policy
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
17
|
|
|
|
|
|
|
|
|
|
|
|
|
Kathryn M. Hill |
|
|
|
Experience
•Numerous
executive-level positions at Cisco Systems, Inc., a communications
and information technology company, including Executive Advisor
(2011 – 2013); Senior Vice President, Development Strategy and
Operations (2009 – 2011); Senior Vice President, Access Networking
and Services Group (2008 – 2009); Senior Vice President, Ethernet
Systems and Wireless Technology Group (2005 – 2008); and other
roles of increasing responsibility
•Various
engineering positions of increasing responsibility at Hughes
Network Systems, a satellite internet provider (1982 –
1993)
Other Current Public Company Directorships
•Independent
Director at Moody’s Corporation, a global integrated risk
assessment company (2011 – present)
•Independent
Director at NetApp, Inc., a global cloud-led, data-centric software
company (2013 – present)
Qualifications Provided to Our Board
•Valuable
insight into long-term commercialization strategies, through
experience developing and successfully commercializing large
complex enterprise products and services in multiple Senior Vice
President roles at Cisco Systems
•Practical
knowledge and experience in enhancing our manufacturing and
commercial effectiveness through digital strategies, gained from
leadership experience at large technology companies, including
service on Cisco’s development council
•Long
tenure at large technology companies and board membership at
high-profile and complex technology-driven companies enabling her
to advise the Board and management very effectively on governance
and information security matters while chairing the EHSQPP
Committee
Education
•B.S.
in Mathematics, Rochester Institute of Technology
|
|
|
Director since:
2015
Age: 66
Current Board Committees:
Compensation
Environmental, Health, Safety, Quality & Public
Policy
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
18
|
|
|
|
|
|
|
|
|
|
|
|
|
David F. Hoffmeister |
|
|
|
Experience
•Senior
Vice President and Chief Financial Officer of Life Technologies
Corporation, a global life sciences company, prior to its
acquisition by ThermoFisher Scientific Inc. (2008 –
2014)
•Chief
Financial Officer of Invitrogen Corporation, a biotechnology
company which merged with Applied Biosystems to form Life
Technologies Corporation (2004 – 2008)
•Senior
partner at McKinsey & Company serving clients in the
healthcare, private equity and chemical industries on issues of
strategy (1984 – 2004), including as leader of McKinsey’s North
American chemical practice (1998 – 2004)
Other Current Public Company Directorships
•Independent
Director at Glaukos Corporation, an ophthalmic medical technology
and pharmaceutical company (2014 – present)
•Independent
Director at ICU Medical Inc., a global leader in infusion systems,
infusion consumables, and high-value critical care products (2018 –
present)
•Independent
Director at StepStone Group Inc., a private markets investment firm
(2020 – present)
Notable Affiliations
•Director
at Kaiser Permanente, a private non-profit integrated managed care
consortium (2014 – present)
Qualifications Provided to Our Board
•Long-standing
knowledge of chemical and materials manufacturing, including from
his time as the head of McKinsey’s North American chemical practice
and as CFO of multibillion dollar life sciences
companies
•Valuable
experience to effectively guide our efforts to grow our Engineered
Materials business gained from deep knowledge of the medical and
pharmaceutical industries through prior roles
•Strong
insight into successful acquisition execution, integration and
synergy capture from leading, as CFO, the multibillion dollar
merger and integration of two life sciences companies into a
combined company, Life Technologies, with approximately 10,000
employees, and then playing an integral role in that company’s
later $14 billion acquisition by Thermo Fisher
Education
•B.A.
in business administration and management, University of
Minnesota
•MBA,
University of Chicago Booth School of Business
|
|
|
Director since:
2006
Age:
68
Current Board Committees:
Audit
Nominating and Corporate Governance
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
19
|
|
|
|
|
|
|
|
|
|
|
|
|
Dr. Jay V. Ihlenfeld |
|
|
|
Experience
•Senior
Vice President, Asia Pacific (2006 – 2012), for 3M Company, a
leader in technology and innovation; Senior Vice President,
Research and Development (2002 – 2006); Various other leadership
and technology positions, including Vice President of the
Performance Materials business and Executive Vice President of the
Sumitomo/3M business in Japan, over 33 years
Other Current Public Company Directorships
•Independent
Director at Ashland, Inc., a premier global specialty materials
company (2017 – present)
Notable Affiliations
•Minnesota
Orchestra
•University
of Wisconsin-Madison College of Engineering Industrial Advisory
Board
•Phi
Delta Theta Foundation Trustee Emeritus
Qualifications Provided to Our Board
•Extensive
experience related to research, development, innovation and
commercialization of chemical and performance materials products in
multiple regions around the globe, which engineering and business
knowledge is invaluable to the Board’s oversight of our product
innovation, development and commercialization
initiatives
•A
strong global perspective, from experience including his time as
3M’s Senior Vice President, Asia Pacific and Executive Vice
President of 3M’s Sumitomo partnership, is highly beneficial to the
Board’s and management’s understanding of global business and
geopolitical considerations, particularly as the M&M
acquisition expands our end market presence in the Asia-Pacific
region
•Deep
experience in environmental and manufacturing strategy in the
chemical sector, which helps guide the Board’s oversight of our
operational sustainability efforts
Education
•B.S.
in chemical engineering, Purdue University
•PhD
in chemical engineering, University of
Wisconsin-Madison
|
|
|
Director since:
2012
Age: 71
Current Board Committees:
Compensation
Environmental, Health, Safety, Quality & Public
Policy
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
20
|
|
|
|
|
|
|
|
|
|
|
|
|
Deborah J. Kissire |
|
|
|
Experience
•Vice
Chair and Regional Managing Partner, member of the Americas
Executive Board and member of the Global Practice Group and various
other various leadership positions, including Vice Chair and
Regional Managing Partner for the East Central and Mid-Atlantic
Regions and U.S. Vice Chair of Sales and Business Development, over
a more than 35 year career at Ernst & Young LLP, an independent
registered public accounting firm (1979 – 2015)
Other Current Public Company Directorships
•Independent
Director at Cable One, Inc., a leading American cable and internet
service provider (2015 – present)
•Independent
Director at Omnicom Group Inc., a global marketing and corporate
communications holding company (2016 – present)
•Independent
Director at Axalta Coating Systems Ltd., a leading provider of
liquid and powder coatings (2016 – present)
Notable Affiliations
•Advisory
Board for Texas State University’s McCoy College of
Business
•Goodwill
Industries of Greater Washington
•Junior
Achievement USA
Qualifications Provided to Our Board
•Ms.
Kissire’s more than 35-year career and leadership roles at Ernst
& Young, together with her service on other large public
company audit committees, bring to our Audit Committee a thorough,
multi-industry perspective to the complexities of our strategic
planning, balance sheet and cash management, risk oversight and
financial reporting
•Experience
leveraging her leadership skills and vision for strategic firm
initiatives and programs at Ernst & Young in global branding,
governance, and gender inclusiveness, such as their Partner
Advisory Council, Strategy Task Force, Gender Equity Task Force,
Vision 2000 Sales Task Force, and global Vision 2020 – which brings
to our Board valuable experience in these areas key to our
strategy
Education
•BBA
in accounting, Texas State University
|
|
|
Director since:
2020
Age: 65
Current Board Committees:
Audit
Environmental, Health, Safety, Quality & Public
Policy
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
21
|
|
|
|
|
|
|
|
|
|
|
|
|
Michael Koenig
|
|
|
|
Experience
•Chief
Executive Officer and a member of the board of directors of Nobian
Industrial Chemicals B.V., a privately-held European leader in the
production of essential chemicals that spun out of Nouryon (2021 –
present)
•Chief
Executive Officer of ELKEM ASA, a publicly-listed and
Norwegian-headquartered global supplier of silicon-based advanced
materials (2019 – 2021)
•Chief
Executive Officer of China National Bluestar Group, a specialty
chemicals company (2016 – 2019)
•Multiple
senior executive positions in Germany and China at Bayer AG, a life
sciences company (1990 – 2015)
•Former
Executive Board Member at Elkem ASA (2016 – 2021)
•Former
Independent Director at Conzzeta AG, a sheet-metal processing
company now known as Bystronic AG (2016 – 2021)
Other Current Public Company Directorships
•Independent
Chair of Symrise AG, a publicly-listed developer and producer of
food and cosmetic flavor and fragrance ingredients headquartered in
Germany (2020 – present)
Qualifications Provided to Our Board
•Current
and recent service as CEO of multibillion dollar chemical
manufacturers – with thousands of employees and operations in
dozens of countries – bringing additional expertise to our complex
global manufacturing, distribution and sales
operations
•Deep
expertise in global markets where we have significant operations
and customer bases including China, where he worked and served as a
senior chemicals and materials executive for nearly fifteen years,
and Europe, where he has been CEO and board member of multiple
large chemical manufacturing companies, which brings geopolitical
and cross-border expertise to the execution of our global strategy
in markets around the world
•Service
as a CEO and board member of multiple companies headquartered in
Europe brings a valuable perspective to our customer and
sustainability efforts in that region
Education
•M.S.
in chemical process engineering, TU Dortmund
University
|
|
|
Director since:
2022
Age: 59
Current Board Committees:
Compensation
Environmental, Health, Safety, Quality & Public
Policy
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
22
|
|
|
|
|
|
|
|
|
|
|
|
|
Kim K.W. Rucker |
|
|
|
Experience
•Executive
Vice President, General Counsel and Secretary of Andeavor, an
integrated marketing, logistics and refining company, and of
Andeavor Logistics LP, a midstream energy infrastructure and
logistics company, from 2016 until Andeavor was acquired by
Marathon Petroleum Corporation (2016 – 2018), including time as
interim Chief Human Resources Officer
•Executive
Vice President Corporate & Legal Affairs, General Counsel and
Corporate Secretary of Kraft Foods Group, Inc., a food and beverage
company (2012 – 2015)
•Senior
Vice President, General Counsel and Chief Compliance Officer of
Avon Products, Inc., a global manufacturer of beauty and related
products and beginning in 2009 assumed additional duties as
Corporate Secretary (2008 – 2012)
•Senior
Vice President, Secretary and Chief Governance Officer of Energy
Future Holdings Corp., an energy company (2004 – 2008)
•Corporate
Counsel for Kimberly-Clark Corporation
•Partner
in the Corporate & Securities group at the law firm of Sidley
Austin LLP
Other Current Public Company Directorships
•Independent
Director at HP Inc., a leading technology company (2021 –
present)
•Independent
Director at Lennox International Inc., a global provider of climate
control solutions (2015 – present)
•Independent
Director at Marathon Petroleum Corporation a leading, integrated,
downstream energy company (2018 – present)
Notable Affiliations
•Haven
for Hope
•Johns
Hopkins Medicine Board of Trustees
Qualifications Provided to Our Board
•Business,
legal and regulatory experience as an executive leader and general
counsel and chief compliance officer in oil and gas, food and
beverage and personal care industries, and board roles in multiple
customer-facing companies, brings a multi-industry,
multi-disciplinary perspective to our Board’s oversight of the
Company’s operational, governance, regulatory affairs and risk
controls management
•Leadership
in negotiating, executing and integrating multiple large and
high-profile acquisitions recently – including the $45 billion
buyout that created Energy Future Holdings (at the time the largest
leveraged buyout in history), the $45 billion merger of Kraft Foods
Group with Heinz to create the world’s fifth largest food and
beverage company, Andeavor’s $6 billion acquisition of Western
Refining Logistics and the acquisition of Andeavor by Marathon
Petroleum for over $20 billion – brings highly-valuable expertise
regarding business strategy, complex M&A, and
integration
•Broad
knowledge of law, business transactions, corporate governance,
compliance, communications, crisis management, government affairs,
human capital and community involvement gained as an executive and
director of multiple public companies, including numerous board
leadership roles. Brings current and expert perspective and
leadership experience on various matters, including strategy, risk
management and board practices
Education
•BBA
in economics, University of Iowa
•M.A.
in public policy, John F. Kennedy School of Government at Harvard
University
•J.D.,
Harvard Law School
|
|
|
Director since:
2018
Age: 56
Current Board Committees:
Audit
Nominating and Corporate Governance
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
23
|
Vote Required
Each director must receive a majority of the votes cast in favor of
his or her election.
Recommendation of the Board
THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT SHAREHOLDERS
VOTE
“FOR” EACH OF THE NOMINEES LISTED ABOVE
Board and Committee Governance
Director Elections
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All Celanese directors are elected annually.
As part of its efforts to maintain a board composed of high-quality
directors able to effectively serve the Company’s strategic needs,
the NCG Committee evaluates the qualifications and performance of
each incumbent director before recommending the nomination of that
director for an additional term.
Our Board proactively adopted a by-law, which permits a
shareholder, or a group of up to 20 shareholders, owning at least
three percent of the Company’s outstanding Common Stock
continuously for at least three years, to submit director nominees
for up to the greater of two directors or 20 percent of the number
of directors currently serving on the Board, subject to the terms
and conditions specified in the by-laws.
|
|
|
Proxy Access
|
|
|
|
Holders of at least
|
|
|
|
3% |
|
|
|
held by up to 20 shareholders
|
|
|
|
Holding the shares
|
|
|
|
continuously for at least
|
|
|
|
3 |
|
|
|
years
|
|
|
|
Can nominate 2 candidates or
|
|
|
|
20% |
|
|
|
of the Board, whichever is greater, for election at an annual
shareholders’ meeting
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Majority Voting Standard
Our by-laws provide that, in an uncontested election, like this
one, each director must receive the majority of the votes cast with
respect to that director (meaning that the number of shares voted
“for” a director must exceed the number of shares voted “against”
that director). If an incumbent director does not receive a
majority vote, he or she has agreed that a letter of resignation
will be submitted to the Board. The NCG Committee will make a
recommendation to the Board on whether to accept or reject the
resignation, or whether other action should be taken. The Board
will act on the resignation within 90 days of the certification of
the vote and will also promptly publicly disclose its decision
regarding the director’s resignation. The Board’s decision will
take into account the recommendation of the NCG Committee, which
will include consideration of the vote result, the director’s
contributions to the Company during his or her tenure, the
director’s qualifications, any relevant input from shareholders,
along with any other factors the NCG Committee deems relevant. The
director who has tendered a resignation will not participate in the
deliberations.
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
24
|
Composition of the Board of Directors
Our certificate of incorporation provides that the number of
members of the Board of Directors shall be fixed by the Board, but
shall be no less than seven and no more than fifteen. Our Board may
fill vacancies and increase or, upon the occurrence of a vacancy,
decrease the Board’s size between annual shareholder meetings. As
of the date of this Proxy Statement, we have, and the Board has
established the size of the Board to be, 11 directors (which will
be reduced to 10 following the Annual Meeting as Mr. Ghai is not
seeking re-election.) Our Board of Directors is and shall be
comprised of a majority of independent directors. See
“Director
Independence and Related Person Transactions”
for additional information.
The Company has a director retirement guideline set forth in our
corporate governance guidelines. The guideline provides that a
director should retire from the Board no later than the annual
meeting of shareholders following such director’s
75th birthday;
provided, however, the retirement guideline may be waived by a
majority of disinterested directors upon the recommendation of the
NCG Committee. Because directors gain valuable experience and
knowledge of our complex business operations through multiple years
of service, and because it has a balance of newer and
longer-serving members, the Board has determined that members
should not be subject to mandatory term limits. Such limits could
result in the premature loss of a director who continues to
significantly contribute to deliberations assessing our strategies,
operations and risks. We believe that our Board’s decision not to
establish mandatory term limits is consistent with the prevailing
practice among companies in the S&P 500.
Annual Board and Committee Self-Evaluation Process
Each year, the members of the Board and each committee conduct a
self-assessment. The process for the self-assessment is approved by
the Board each year based on a recommendation from the NCG
Committee. The NCG and the Board regularly review and make
refinements to the annual assessment process.
Under the process used in 2022, the NCG Committee developed a
thorough list of topics to be considered by the directors. These
topics were incorporated into a Board questionnaire completed by
each director and committee-specific questionnaires for each
committee. After completion of the questionnaires, our NCG
Committee Chair held virtual conferences with each independent
director, including the Lead Independent Director, as well as the
Chair, to discuss the topics and to gather any other feedback a
director has as they relate to the Board and each committee. The
input from the questionnaires and conversations was summarized and
presented to the full Board (and to the independent directors as to
the CEO) and to the individual committees at the October Board and
committee meetings. An overview of this process is illustrated
below.
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
25
|
|
|
|
|
|
|
|
|
|
Board and Committee Self-Evaluation Process Summary
|
Process Design and Approval |
v |
Discussion among management and NCG Chair regarding key topics for
assessment and creation of the Board and Committee
questionnaire. |
|
Topics generally include Board and committee structure, oversight,
allocation of responsibilities among committees, approach to
meetings, individual director assessments, culture and current
strategic or business topics of particular importance. |
v |
NCG Committee recommends process for Board approval in
July. |
Questionnaire |
v |
Board members complete and provide comments on detailed
questionnaire. |
|
Includes specific questions and topics for each
committee. |
One-on-One Conversations |
v |
NCG Chair holds one-on-one conversations with each director to
discuss feedback and comments on the questionnaire, and any other
topics a director wishes to raise. |
v |
NCG Chair confers with the Chair/CEO and Lead Independent Director
so that they understand any opportunities for improvement that may
have been raised.
|
Report-Out to Committees and Board |
v |
Feedback is reported to the Board and individual committees at the
October meeting. |
v |
The Board and each committee hold dedicated closed executive
sessions in October to discuss assessment and provide any feedback
to management. |
Implementation of Feedback |
v |
Management and directors coordinate to update policies and
practices to incorporate director feedback. |
v |
The Board reviews implementation progress in connection with the
following year’s self-evaluation process. |
|
Enhancements implemented from the most recent self-evaluation
included director education, refined cadence of certain agenda
topics, refinements to the Board’s approach in overseeing cyber and
supply chain risks, and review and refreshment of certain company
policies. |
Also, the NCG Committee and full Board evaluate directors who are
nominees for re-election to the Board as part of the nomination
process.
Board Leadership Structure
The Company’s governance framework provides the Board with
flexibility to select the appropriate leadership structure for the
Company. In making leadership structure determinations, the Board
considers many factors, including the specific needs of the
business and what is in the best interests of the Company’s
shareholders. The Board welcomes and takes under consideration any
input received from our shareholders regarding the Board’s
leadership structure and informs shareholders of any change in the
Board’s leadership structure through press releases or, as
applicable, by posting amended corporate governance guidelines on
the Company’s website.
In April 2020, the Board elected our Chief Executive Officer Lori
Ryerkerk to serve as Chair of the Board. The Board made this
election as part of the planned transition of leadership from our
prior CEO Mark Rohr. Therefore, the current leadership structure is
comprised of a combined Chair of the Board and Chief Executive
Officer, a Lead Independent Director, and Board committees
comprised exclusively of and chaired by independent directors,
together with active engagement by all directors. The Board
believes that the current leadership structure is effective and
currently serves the business and shareholders well. The Board also
believes that combined leadership of the Board and the Company by
Ms. Ryerkerk is currently the optimal structure to guide the
Company, provide consistent leadership and maintain the focus
required to achieve our long-term business goals.
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
26
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Board Leadership Structure |
|
The Board believes this is currently the optimal structure to
provide consistent leadership and to maintain the focus required to
achieve the Company’s strategic plan and long-term business goals.
The NCG Committee and the Board will continue to reevaluate the
structure annually.
|
|
●
|
Chair and Chief Executive Officer: Lori Ryerkerk
|
|
|
●
|
Lead Independent Director: William Brown (since April
2021)
|
|
|
●
|
All Board committees comprised entirely of independent
directors
|
|
|
●
|
Active engagement by all directors
|
|
|
|
Duties and Responsibilities of Lead Independent
Director
The duties and responsibilities of the Company’s Lead Independent
Director are set forth in our Lead Independent Director Policy,
which is part of our corporate governance guidelines. The Company’s
Lead Independent Director, who is elected by the independent
directors for a one-year term:
•presides
over executive sessions of the independent members of the Board and
at meetings of the Board in the absence of, or upon the request of,
the Chair;
•approves
the scheduling of Board meetings, as well as the agenda and
materials for each Board meeting and executive session of the
Board’s independent directors, as well as advising on the quality
or quantity of information provided to the Board;
•has
the authority to call meetings of the Board and such other meetings
of the independent directors as he/she deems
necessary;
•serves
as a liaison and supplemental channel of communication between the
independent directors and the Chair/CEO;
•meets
regularly with and advises the Chair/CEO;
•communicates
with shareholders and other external stakeholders as requested and
deemed appropriate by the Board, and speaks on behalf of the Board
in circumstances where the Chair is not available;
•interviews
director candidates along with the NCG Committee;
•approves
and coordinates the retention of advisors and consultants who
report directly to the independent members of the Board, except as
otherwise required by applicable law or the New York Stock Exchange
(“NYSE”) Listing Standards;
•guides
the Board’s governance processes concerning the annual Board
self-evaluation and CEO succession planning; and
•when
requested by the Chair or the Board, assists the Board in reviewing
and promoting compliance with governance principles.
Leadership Structure Determination
Consistent with the Board’s commitment to corporate governance
practices that are in the best interests of the Company and its
shareholders, at least one executive session of the directors each
year includes a review of the Board’s leadership structure and a
consideration of whether the position of Chair of the Board should
be held by the Chief Executive Officer or an independent
director.
Under the Company’s by-laws, the Chair presides over meetings of
the Board, presides over meetings of shareholders and performs such
other duties as may be assigned by the Board. The Chief Executive
Officer is generally in charge of the daily affairs of the Company,
subject to the overall direction and supervision of the Board and
its committees and subject to such powers as reserved by the Board.
Lori Ryerkerk currently serves as Chair of the Board and Chief
Executive Officer.
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
27
|
The Board has had a Lead Independent Director role for more than a
decade. In February 2021, the independent directors elected William
M. Brown to serve as Lead Independent Director beginning after the
2021 Annual Meeting (held in April 2021), and the independent
directors re-elected Mr. Brown as Lead Independent Director to
successive annual terms in February 2022 and February 2023.
The Lead Independent Director is elected annually, and is generally
expected to serve for not more than three to five years. Having
served as Chair and CEO of L3Harris Technologies and Harris
Corporation, two multibillion dollar public companies with
thousands of employees, Mr. Brown brings to the Lead Independent
Director role high-level executive, operational, risk oversight and
corporate governance experience. The Board believes he is
well-positioned to guide our Board and advise our Chair/CEO on
enterprise strategy and risk.
Importantly, all directors play an active role in overseeing the
Company’s business both at the Board and committee levels. As set
forth in the Company’s corporate governance guidelines, the core
responsibility of the directors is to exercise their business
judgment to act in what they reasonably believe to be in the best
interests of the Company and its shareholders. The Board, including
all of the nine independent nominees, consists of skilled and
experienced leaders in business. Many directors currently serve or
have served as chief executives or members of senior management of
Fortune 1000 companies and/or as senior leaders in top consulting,
accounting and law firms. In these prior roles, the independent
directors have been called upon to provide solutions to various
complex issues and are expected to, and do, ask hard questions of
management. As such, the independent directors are well-equipped to
oversee the success of the business and to provide advice and
counsel to our CEO and management.
As part of each regularly scheduled Board meeting, the independent
directors meet in executive session without the Chair/CEO present.
These meetings allow independent directors to discuss issues of
importance to the Company, including the business and affairs of
the Company, as well as matters concerning management, without any
member of management present. All of our Board committees are
chaired by and consist entirely of independent
directors.
Director Membership on Other Boards
Each of our directors is expected to have sufficient time and
capacity to serve as an effective Board member and to carry out his
or her duties to the Company and our shareholders. To this end, our
corporate governance guidelines limit the number of other boards on
which our directors serve. No director may serve on more than four
public company boards including ours without the prior approval of
the NCG Committee (but in no event shall a director serve on more
than six public company boards). The Board also recognizes the time
commitment associated with service as a public company executive
officer, and therefore applies a tighter limit to any non-employee
director who serves as a CEO or executive of another public
company: generally such directors may serve on our Board and the
board of their employer. The NCG Committee may approve up to one
additional board and the full Board may approve additional service
for particular directors (up to the previously-stated limit),
following consideration of such factors deemed appropriate such as
individual’s role, experience, diversity, background and other
leadership positions. To date, neither the NCG Committee nor the
Board has exercised this authority to approve additional service.
Directors are expected to advise the Board Chair and the NCG
Committee Chair in advance of accepting an invitation to serve on
another company’s board.
Recognizing that directors’ responsibilities are increasingly
complex and that Board and committee memberships demand significant
time commitments, our Board regularly evaluates the other
commitments of director candidates during the nomination process,
and of its existing directors as part of the annual nomination and
Board self-assessment processes to confirm that they can devote the
time and energy required to be effective representatives of
shareholders’ interests.
Board Meetings in 2022
The Board of Directors held seven meetings during 2022 and
committees of the Board held a total of 22 meetings. Overall
attendance at such meetings was 96%. Therefore all incumbent
directors attended at least 75% of the aggregate of
(i) meetings of the Board and (ii) meetings of the Board
committees on which they served during the
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
28
|
fiscal year ended December 31, 2022. In addition, the Board
expects directors to attend the annual meeting of shareholders
absent special circumstances. All of our directors then serving
attended our 2022 Annual Meeting.
Committees of the Board
The Board of Directors has four standing Board
committees:
•Audit
Committee;
•Compensation
and Management Development Committee;
•Nominating
and Corporate Governance Committee; and
•Environmental,
Health, Safety, Quality and Public Policy Committee.
The following table sets forth our nominees’ membership on our
committees:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Independent Director |
Audit Committee |
Compensation and Management Development Committee |
Environmental, Health, Safety, Quality and Public Policy
Committee |
Nominating and Corporate Governance Committee |
Jean S. Blackwell
À
|
ü |
l |
|
|
l |
William M. Brownt
|
ü |
|
l |
|
l |
Edward G. Galante |
ü |
|
£ |
l |
|
Kathryn M. Hill |
ü |
|
l |
£ |
|
David F. Hoffmeister
À
|
ü |
l |
|
|
l |
Dr. Jay V. Ihlenfeld |
ü |
|
l |
l |
|
Deborah J. Kissire
À
|
ü |
£ |
|
l |
|
Michael Koenig |
ü |
|
l |
l |
|
Kim K.W. Rucker |
ü |
l |
|
|
£ |
Lori J. Ryerkerk |
|
|
|
|
|
Meetings in 2022
|
Board = 7
|
9 |
5 |
4 |
4 |
£
Chairperson
l
Member
À
Financial Expert
u
Lead Independent Director
|
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
29
|
Audit Committee
The Company’s Audit Committee (the “Audit Committee”) is currently
comprised of Ms. Kissire (chair), Ms. Blackwell, Mr. Ghai, Mr.
Hoffmeister and Ms. Rucker, each of whom the Board has
affirmatively determined is independent of the Company and its
management under the rules of the NYSE and the SEC. The Board has
also determined that Ms. Blackwell, Mr. Ghai, Mr. Hoffmeister
and Ms. Kissire are “Audit Committee Financial Experts” as the term
is defined in applicable SEC rules. Each member of the Audit
Committee is also “financially literate” as that term is defined by
the rules of the NYSE. The complete text of the Audit Committee
charter, as last reviewed and approved by the Board of Directors on
July 13, 2022, is available on our website,
https://investors.celanese.com, by clicking “Corporate
Governance.”
The Audit Committee is directly responsible for the appointment,
compensation and oversight of the work of the Company’s independent
registered public accounting firm. The independent registered
public accounting firm reports directly to the Audit Committee. The
principal purposes of the Audit Committee are to
oversee:
•accounting
and reporting practices of the Company and compliance with legal
and regulatory requirements regarding such accounting and reporting
practices;
•the
quality and integrity of the financial statements of the
Company;
•internal
control and compliance programs;
•the
independent registered public accounting firm’s qualifications and
independence; and
•the
performance of the independent registered public accounting firm
and the Company’s internal audit function.
The Audit Committee Charter provides that the Audit Committee may,
in its sole discretion and at the Company’s expense, retain legal,
accounting or other consultants or experts it deems necessary in
the performance of its duties and without having to seek the
approval of the Board.
Mr. Hoffmeister serves on the audit committees of three other
publicly-traded companies in addition to ours. Our Board has
affirmatively determined that Mr. Hoffmeister’s simultaneous
service on these other audit committees does not impair his ability
to effectively serve on our Audit Committee.
Compensation and Management Development Committee
The Company’s Compensation and Management Development Committee
(the “CMDC”) is currently comprised of Mr. Galante (chair), Mr.
Brown, Ms. Hill, Dr. Ihlenfeld and Mr. Koenig. The Board has
determined that all members of the CMDC are independent under
Rule 16b-3 under the Securities Exchange Act of 1934, as
amended, and applicable NYSE listing standards, and qualify as
“non-employee directors” for purposes of Section 162(m) of the
Internal Revenue Code. The complete text of the CMDC charter, as
last amended by the Board of Directors on July 13, 2022, is
available on our website, https://investors.celanese.com, by
clicking “Corporate Governance”. A description of the CMDC’s
processes and procedures for determining executive compensation and
the roles of management and the compensation consultant in
determining or recommending the amount and form of compensation is
more fully described in
“Compensation
Discussion and Analysis.”
The principal purposes of the CMDC are to:
•review
and approve the compensation of the Company’s executive
officers;
•review
and approve the corporate goals and objectives relevant to the
compensation of the CEO and the other executive officers, and to
evaluate the CEO’s and the other executive officers’ performance
and compensation in light of such established goals and
objectives;
•oversee
the development and implementation of succession plans for the CEO
and the other key executives; and
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
30
|
•oversee
and review the Company’s strategies and policies in the areas of
human capital management, including talent development, diversity,
equity and inclusion.
The CMDC charter provides that the CMDC may, in its sole discretion
and at the Company’s expense, retain legal, accounting or other
consultants or experts, including but not limited to compensation
consulting firms, that the CMDC deems necessary in the performance
of its duties.
Nominating and Corporate Governance Committee
The Company’s NCG Committee is currently comprised of Ms. Rucker
(chair), Ms. Blackwell, Mr. Brown, Mr. Ghai and Mr. Hoffmeister.
The complete text of the NCG Committee charter, as last reviewed
and approved by the Board of Directors on July 13, 2022, and
our corporate governance guidelines, as last reviewed and approved
by the Board of Directors on October 19, 2022, are available
on our website, https://investors.celanese.com, by clicking
“Corporate Governance.”
The principal purposes of the NCG Committee are to:
•identify,
screen and review individuals qualified to serve as directors and
recommend candidates for nomination for election at the annual
meeting of shareholders or to fill Board vacancies;
•review
and recommend independent director compensation to the
Board;
•develop
and recommend to the Board and oversee implementation of the
Company’s corporate governance guidelines;
•oversee
evaluations of the Board;
•recommend
to the Board nominees for the committees of the Board;
and
•review
and assess our Board’s and the committees’ structure for overseeing
ESG matters; review and oversee our strategy and processes for
public reporting on ESG and sustainability matters; and oversee our
and our political action committee’s political engagement
initiatives.
The NCG Committee charter provides that the NCG Committee may, in
its sole discretion and at the Company’s expense, retain legal,
accounting and other consultants or experts, including but not
limited to leadership search firms, the NCG Committee deems
necessary in the performance of its duties, including in its
process of identifying director candidates.
During 2022, WTW, as independent outside compensation consultant,
advised the NCG Committee on non-employee director compensation
matters.
Environmental, Health, Safety, Quality and Public Policy
Committee
The Company’s Environmental, Health, Safety, Quality and Public
Policy Committee (the “EHS Committee”) is currently comprised of
Ms. Hill (chair), Mr. Galante, Dr. Ihlenfeld, Ms. Kissire and
Mr. Koenig. The EHS Committee assists the Board in fulfilling its
oversight duties regarding, while Company management retains
responsibility for assuring compliance with, applicable
environmental, health and safety laws and regulations. The complete
text of the EHS Committee charter, as last amended by the Board of
Directors on July 13, 2022, is available on our website,
https://investors.celanese.com, by clicking “Corporate
Governance.”
The principal purposes of the EHS Committee are to:
•oversee
the Company’s policies and practices concerning environmental,
health, safety, quality and public policy issues;
•review
the impact of such policies and practices on the Company’s ESG and
sustainability responsibilities;
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
31
|
•oversee
the development, implementation and monitoring of greenhouse gas
(GHG) reduction and other sustainability-related investments into
our manufacturing and production processes;
•oversee
management’s review of supply chain risk and cybersecurity risk;
and
•make
recommendations to the Board regarding these matters.
Board Oversight
Shareholders elect the Board to oversee management and to serve
shareholders’ long-term interests. Management is responsible for
delivering on our strategy, creating our culture, creating and
delivering innovative products and services, establishing
accountability, and controlling risk. The Board and its committees
work closely with management to balance and align strategy, risk,
corporate social responsibility, and other areas while considering
feedback from shareholders. Essential to the Board’s oversight role
is a transparent and active dialogue between the Board and its
committees, and management. To support that dialogue, the Board and
its committees have access to, receive presentations from, and
conduct regular meetings with the senior leadership team, other
business and function leaders, subject matter experts, the
Company’s enterprise risk management and internal audit functions,
and external experts and advisors.
Board Oversight of Strategy
One of the Board’s primary responsibilities is overseeing
management’s establishment and execution of the Company’s strategy.
As Celanese continues to transform and expand its business, the
Board works with management to respond to a dynamically changing
environment. At least quarterly, the CEO, the senior leadership
team, and leaders from across the Company provide detailed business
and strategy updates to the Board. At least annually, the Board
conducts an even more in-depth review of the Company’s overall
strategy, including critical issues, risks and opportunities. At
all of these reviews, the Board engages with the senior leadership
team and other business leaders regarding business objectives, the
competitive landscape, economic trends, environmental and
sustainability goals and investments, public policy and regulatory
developments and other critical issues. At meetings occurring
throughout the year, the Board also assesses acquisitions, the
Company’s operating and capital plan, and performance and alignment
to our strategy. The Board looks to the focused expertise of its
committees to inform strategic oversight in their areas of focus.
Members of senior management are available to discuss the Company’s
strategy, plans, results and issues with the Board committees and
the Board, and regularly attend such meetings to provide periodic
briefings and access to management. In addition, the Audit
Committee regularly holds separate executive sessions with the lead
client service partner of our independent registered public
accounting firm, the chief financial officer, the internal auditor,
the chief compliance officer and other members of management as
appropriate.
Board Oversight of Environmental, Social and Governance
Matters
We recognize that our success is defined by multiple groups of
stakeholders – investors, customers, employees, and communities –
and this recognition is reflected in our efforts to promote safety
and protect our environmental resources as a responsible corporate
citizen.
Our CEO Lori Ryerkerk affirmed the need to build the next
generation of sustainability efforts for the Company and formed the
Celanese ESG Council in 2019. Our ESG Council is a cross-functional
team of senior leaders from each region who develop, make
recommendations to management and implement an ESG strategy on
topics significant to Celanese’s long-term success.
The ESG Council meets monthly to form recommendations to senior
leadership on key ESG program strategy and implementation of
ESG-related projects. For example, the ESG Council has made
recommendations on standards reporting alignment and further
development of key KPIs, and has led the publication of the
Company’s comprehensive Sustainability Reports, the most recent of
which is available at sustainability.celanese.com.
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
32
|
The Board of Directors and its committees have conducted an
in-depth review of their approach to overseeing ESG topics most
significant to Celanese (our priority topics). In April 2021, our
Board agreed on a strengthened and clarified framework for
overseeing priority ESG matters by aligning a specific committee or
the full Board to each. The diagram below illustrates primary Board
or committee oversight responsibility by topic.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Public Shareholders |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Board of Directors |
|
|
|
|
|
|
|
|
|
|
|
|
|
ü |
Public Policy and Regulatory Issues |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ü |
Enterprise Climate Policy and Strategy |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ü |
Charitable Giving / Volunteerism |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Audit Committee |
|
CMD Committee |
|
NCG Committee |
|
EHS Committee |
|
|
|
ü |
Compliance and Business Conduct Policy |
|
ü |
Talent and Leadership Development, including Succession |
|
ü |
Board Composition, Independence, Refreshment and ESG Oversight
Approach |
|
ü |
Environmental Policies |
|
|
|
|
|
|
ü |
Process Sustainability |
ü |
Financial Risk |
|
|
|
|
|
ü |
Workforce, Process and Chemical Safety |
ü |
Corporate Integrity |
|
ü |
Executive Compensation and Performance |
|
ü |
Shareholder Rights |
|
|
|
|
|
|
|
|
|
|
|
|
ü |
ESG Metric Reporting |
|
ü |
Supply Chain Risk |
|
|
|
|
|
|
|
|
ü |
Diversity, Equity and Inclusion |
|
ü |
Political Engagement / PAC Oversight |
|
ü |
Product Quality |
|
|
|
|
|
|
|
|
|
|
|
|
ü |
Greenhouse Gas Reduction in Manufacturing Processes |
|
|
|
|
|
|
|
|
ü |
Pay Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ü |
Cybersecurity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Celanese Executive Leadership |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Celanese ESG Council |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consists of cross-functional and regional senior leaders, and
includes the chairs of our ten expert committees. The Council is
responsible for recommending and monitoring progress against goals,
metrics, and KPIs.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Our Board regularly reviews the areas of responsibility of its
committees, including through an annual review of its Committee
Charters and our Corporate Governance Guidelines, and includes as
part of those reviews ESG topics that are most significant to
Celanese. In 2022, the Board determined the EHS Committee is
well-positioned to oversee our cybersecurity efforts, and allocated
that priority topic to such Committee as described in
“Board
Oversight of Risk — Highlight on Oversight of Cybersecurity Risk
and Data Privacy.”
The Company and the Board also receive feedback from shareholders
on ESG issues through our shareholder outreach program and through
communication from shareholders. See “Shareholder
Engagement”
below.
Board Oversight of Risk
Effective risk management is critical to Celanese’s ability to
achieve its strategy and ESG goals. The Board oversees management
in exercising its responsibility for managing risk, considering our
robust framework of policies, procedures, and processes to
anticipate, identify, assess, prioritize, and mitigate risks across
the Company. Risk management is considered a strategic activity
within the Company and responsibility for managing risk rests with
executive management while the committees of the Board and the
Board as a whole participate in the oversight of the process.
Specifically, the Board has responsibility for overseeing the
strategic planning process, reviewing and monitoring management’s
execution of the strategic and business plan, and selected risk
areas, including
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
33
|
cybersecurity. Each Board committee is responsible for oversight of
specific risk areas relevant to their respective committee charter.
The oversight responsibility of the Board and the Board committees
is enabled by an enterprise risk management model and process
implemented by management that is designed to identify, assess,
manage and mitigate risks. In addition, the Directors identify
risks through the Board and committee self-assessment process and
hears from a range of outside advisors and experts regarding trends
and emerging risks. The Board further recognizes that risk
management and oversight comprise a dynamic and continuous process
and reviews the enterprise risk model and process periodically. On
a regular basis, the Board and its committees engage with
management, including the chief compliance officer, who reports to
the general counsel, on risk as part of broad strategic and
operational discussions which encompass interrelated risks, as well
as on a risk-by-risk basis.
The Board executes its oversight responsibility directly and
through its committees. It delegates oversight of some risks to
efficiently allocate them to appropriate committees with related
subject matter focus while retaining oversight of risks that
require broader Board attention. Because many risks are dynamic,
interrelated, and applicable across subject matter and company
goals, the Board may continue to oversee such risks in addition to
delegating some oversight to a committee.
Committees discuss the Company’s risk exposures with management,
the internal audit executive and the independent external auditor
in an iterative risk assessment process. Results of risk audits are
routinely reported to leadership and the Audit Committee, which
regularly reports back to the Board. Some examples of risks
overseen by committees and the Board are:
•The
Audit Committee regularly reviews and assesses the Company’s
processes to manage financial reporting risk and to manage internal
audit, internal control over financial reporting and disclosure
controls and procedures, tax, investment, and other financial
risks, as well as the Company’s financial position and financial
activities. The Audit Committee also oversees the Company’s
compliance program.
•The
CMDC oversees compensation programs, policies and practices and
their effect on risk-taking by management. See
“Compensation
Risk Assessment”
for additional information.
•The
NCG Committee oversees the governance framework and structure as
well as other corporate governance matters, including oversight of
the annual Board and committee self-assessment process, and is
charged with developing and recommending to the Board corporate
governance principles and policies and Board committee structure,
leadership and membership.
•The
EHS Committee oversees certain operational risks related to
environmental, process and product safety and quality matters, as
well as reputational issues related to those matters.
•The
full Board oversees the enterprise risk process that management
implements and reviews risks associated with it.
•The
full Board and the CMDC address issues and risks associated with
diversity, equity and inclusion and human capital
management.
•The
full Board and the EHS Committee oversee cybersecurity
risk.
Each of the Board committees is required to make regular reports of
its actions and any recommendations to the Board with respect to
risk management, including recommendations to assist the Board with
its overall risk oversight function. In addition, an annual report
of enterprise risks, which undergo a comprehensive review using
strategic, operational, financial, compliance and IT risk themes,
is delivered to the Board. This approach to risk oversight does not
affect the Board’s leadership structure.
Each of our directors has substantial experience managing and
overseeing risk for complex, international organizations that they
leverage while serving on our Board. For example, Ms. Ryerkerk’s
experience as our chief executive officer, Mr. Brown’s past
experience leading L3 Harris Technologies, Inc. as its chief
executive officer and Mr. Koenig’s experience leading Nobian
Industrial Chemicals as its chief executive officer each
necessitate risk management and oversight on a daily basis. The
extensive chemical industry leadership experience shared by Mr.
Galante, Dr. Ihlenfeld and Ms. Ryerkerk, as well as Ms. Hill’s
leadership experience in technology, allow each of
them
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
34
|
to understand and address key risk-related issues unique to our
industry and the Company. Risk management was an active component
of Mr. Hoffmeister’s responsibilities as chief financial officer
for Life Technologies and Ms. Kissire’s senior leadership positions
with Ernst & Young LLP. Finally, the management, leadership,
accounting and legal backgrounds of Ms. Blackwell, Ms. Kissire and
Ms. Rucker allow them unique perspectives with recognizing and
advising on a broad array of issues affecting corporate
risk.
Highlight on Oversight of Human Capital Management
The Board, the CMDC, and the EHS Committee engage with the senior
leadership team and human resources executives on a regular basis
across a broad range of human capital management issues. Celanese
is focused on creating a respectful, safe, rewarding, diverse, and
inclusive work environment that allows our people to build
meaningful careers. The success of these human capital management
objectives is important to the fulfillment of our strategy, and the
Board works with management to provide oversight on matters
including culture, succession planning and development,
compensation, benefits, employee recruiting and retention,
diversity, equity and inclusion and respectful workplace.
Additionally, each year, the CMDC evaluates management’s annual
assessment of risk related to our compensation policies and
practices. The Board and the CMDC work with the CEO and the Senior
Vice President and Chief Human Resources Officer to review CEO and
senior executive succession plans, including considering the
qualifications and experience of potential leadership candidates.
For more detail please see “Compensation
Discussion
and Analysis —
CD&A
Highlights
—
Human
Capital Management.”
Highlight on Oversight of Cybersecurity Risk and Data
Privacy
The Board and the EHS Committee are both involved in oversight of
the Company’s management of cybersecurity risk, reflecting the
Board’s view of the benefits of periodic reporting on a range of
cybersecurity issues to a dedicated subset of directors.
Cybersecurity protection is vital to maintaining our proprietary
information and the trust of our customers and employees. We
recognize the importance of securing our data and information
systems from potential breaches. Management provides regular
updates to the EHS Committee on the Company’s cybersecurity
policies and performance at least annually and periodically
throughout the year, including information about cybersecurity
governance processes, the status of projects to strengthen internal
cybersecurity, and the results of assessments and security breach
simulations. The Board and the EHS Committee also discuss recent
incidents throughout the industry and the emerging threat
landscape.
In 2021, we launched a comprehensive cybersecurity awareness course
in our learning management system covering key topics such as
identifying workplace cyber hazards and attacks. In 2022, we added
updated content monthly in multiple languages. Our CyberSAFE
intranet is a one-stop for quick and consumable content to help
employees identify and avoid cybersecurity risks.
To protect the Company, we maintain cyber/information security
insurance with coverage for security incident response expenses,
certain losses due to network security failures, investigation
expenses, privacy liability and certain third-party
liability.
Highlight on Oversight of Climate Risk
Climate risk has the potential to impact many aspects of the
Company’s strategy, so the Board has determined to retain oversight
of the Company’s climate policy and strategy as a whole and has
delegated to its Committees specific aspects of managing climate
risk as described below.
The Company has set meaningful environmental goals to reach by
2030, including a 30% reduction in Scope 1 and 2 greenhouse gas
emissions intensity, 10% reduction in net energy intensity, 10%
reduction in water consumption intensity, and 15% reduction in
waste disposal intensity, as described in “Environmental,
Social and Governance Update”
in the forepart of this Proxy Statement. Each goal requires
significant input from all areas of the Company to focus the
Company on achieving it and reporting accurate data to monitor
progress and opportunity. The NCG Committee oversees the process by
which the Company reports on these and other metrics.
Climate risk can include related financial and compliance risk.
Management updates the Audit Committee and EHS Committee on the
regulatory landscape and continued compliance activities supporting
the Company’s increased
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
35
|
focus on environmental sustainability. The EHS Committee oversees
management’s greenhouse gas reduction efforts and the
sustainability-related investments in the Company’s manufacturing
and production processes, such as carbon capture and use at our
Clear Lake site. The Board guides and receives reports on our
product strategies to support our customers’ sustainability goals,
such as light-weighting products and producing from bio-based
sources.
Highlight on Oversight of Strategic Acquisitions
The full Board is responsible for overseeing Celanese’s strategic
acquisition and integration process, which supports alignment with
our strategic objectives, provides accountability across
acquisitions, and enables insight for future acquisitions. Our
individual directors have extensive negotiation, acquisition,
integration, and other business combination experience that allows
them to constructively engage with management and effectively
evaluate acquisitions for alignment with our strategy and culture.
Celanese views strategic acquisitions as an important element in
delivering long-term shareholder value. While management is charged
with identifying potential acquisition targets, executing
transactions, and managing integration, our Board’s oversight
extends to each phase. Management and the Board regularly discuss
potential acquisitions of all sizes and degrees of complexity of
integration and their role in the Company’s overall business
strategy. These discussions include acquisitions in process and
potential future acquisitions, focusing on valuation, strategic
risk, and potential synergies with our businesses and strategy.
When management considers potentially significant acquisitions, the
Board receives an increased level and frequency of updates and
discusses with management a broad range of matters, including
negotiations, due diligence findings, valuation, tax impacts,
integration planning, talent retention, environmental and other
risks, and regulatory impacts. Throughout the acquisition process,
the Board has access to the senior leadership team, appropriate
business leaders, subject matter experts, and external advisors. As
part of the entire strategic acquisition lifecycle, the Board also
receives regular updates and provides feedback on ongoing
integration, operational success, and financial performance of our
completed acquisitions (including the M&M Acquisition), which
allows the Board to provide oversight and to identify trends and
opportunities across transactions and over time.
Shareholder Engagement
The Board believes that accountability to shareholders is a mark of
good governance and critical to the Company’s success. To that end,
the Company maintains dedicated resources for regular active
communication with shareholders. The Company regularly engages with
shareholders on a variety of topics throughout the year to address
their questions and concerns, to seek input and to provide
perspectives on Company policies and practices. Topics include
corporate strategy, ESG matters, sustainability, cash deployment,
executive compensation plan design and practices, Board composition
and refreshment and executive succession.
During 2022, we contacted shareholders representing approximately
57% of our shares to offer engagement meetings and met
telephonically in 2022 and early 2023 with shareholders holding
approximately 38% of our shares. At these meetings senior
representatives of our executive, corporate governance, human
resources and investor relations teams met virtually with
shareholder representatives to discuss our strategy, our ESG and
sustainability progress, governance, human capital and executive
compensation.
Shareholder Feedback in 2022 and Early 2023 Related to Our
Strategy, Board and ESG Progress
We have listened intently to the views of shareholders, and the
substantial majority that we spoke to in 2022 and early 2023 were
supportive of our leadership structure, Board composition, our
sustainability disclosures including our most recent 2021-2022
sustainability report,
Accelerating Solutions Through Chemistry,
and our ESG progress. Below is a summary of key topics that we
found to be of interest to our shareholders during this year’s
engagement.
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
36
|
|
|
|
|
|
|
Topics of Interest to Shareholders |
Our Perspective, Actions Taken and Actions Planned |
● Sustainability-focused product opportunities |
● We see significant growth opportunities for products supporting
future mobility, vehicle light-weighting and other end-product
efficiencies as well as solutions manufactured from recycled or
bio-based materials.
● We recently re-designed our website to give customers a clearer
picture of how our growing range of products and solutions can
support their own sustainability goals.
|
Climate-related topics:
● Our progress towards tracking our Scope 3 emissions
● Opportunities to reduce GHG emissions through products and
operations, and associated costs
● Our perspective on net-zero and/or Scope 3 emissions reduction
targets
|
● In 2022, we engaged ERM CVS to provide a limited assurance of our
environmental baseline metrics associated with our 2030
environmental targets as described beginning on page
7,
● We are actively investing in projects to increase our energy
efficiency and our use of renewable energy, including carbon
capture and hydrogen technologies, and have incorporated
sustainability reviews into our capital planning process and
analysis of potential returns.
● We are actively working to integrate the M&M Business’s
reporting processes into our own in 2023, and also exploring our
Scope 3 emissions sources to develop a roadmap to identify,
quantify, and reduce our emissions further.
|
● Recent director searches, Board composition and Board
refreshment |
● We have a highly-qualified and diverse board that brings unique
capabilities across functions, experiences, industries and
backgrounds. The attributes sought by the Board and NCG Committee
are described above beginning on page
12.
● In recent years, the Board and NCG Committee have sought sitting
executives with deep industry, global, M&A and risk experience,
including Mr. Koenig elected in February 2022.
|
|
|
See page
58
for information about discussions with shareholders in 2022 and
early 2023 regarding human capital matters and our executive
compensation programs.
In addition to this direct engagement, the Company has instituted a
number of complementary mechanisms that allow shareholders to
effectively communicate a point of view with the Board,
including:
•a
dedicated annual meeting page on our website (see page
106);
•a
majority voting standard for the election of directors (see
page
24);
•an
annual advisory vote to approve executive compensation (see
page
51);
•annual
election of directors (see page
24);
•proxy
access (see page
24);
•commitment
to thoughtfully consider shareholder proposals submitted to the
Company (see page
111);
and
•providing
shareholders a means for direct communications to individual
directors, a Board committee or the entire Board (see page
111).
How We Have Responded To Shareholder Feedback on Governance Matters
in the Past
We routinely consider shareholder feedback in compensation and
governance matters. In prior years, in response to shareholder
feedback, we eliminated our classified board structure, adopted a
proxy access by-law, extended the PRSU performance period from two
to three years, added a return measure (ROCE) to our long-term
incentive plan, adopted a more enhanced compensation clawback
policy, amended our insider trading policy to further address
anti-hedging and prevent pledging of our Common Stock by our
executive officers and accelerated our publication of disclosures
aligned to the framework of the Task-Force on Climate-Related
Financial Disclosures (TCFD).
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
37
|
Additional Governance Matters
As a global company, Celanese must not only meet a breadth of
varying local, state and regional regulations, but also be mindful
of possible social and political conflicts. We understand the role
corporate governance plays in maintaining our goal to act in
accordance with our values.
Celanese’s Board of Directors is composed of a diverse group of
leaders with experience at major domestic and international
companies. They have worked in key market sectors that reflect our
customer base and have sound financial and governance expertise.
Their experience provides an understanding of business strategies
and impacts, as well as challenges and risks. We encourage our
directors to participate in, and we offer reimbursement for,
director education programs to stay abreast of evolving governance,
regulatory, and other issues. Nine of our 10 nominees are
independent, 50% gender diverse and 10% racially or ethnically
diverse. Copies of our committee charters and other governance
documents are available on our website,
https://investors.celanese.com.
Governance and Compensation Best Practices
Celanese is committed to strong corporate governance and
compensation practices that promote the long-term interests of
shareholders, strengthen board and management accountability and
help build public trust in the Company. Examples are listed on
page
55.
Political Engagement Policy
Although Celanese does not engage in any direct political
contributions, the Company strives to offer fair, thoughtful and
transparent educational advocacy programs to acquaint elected
officials about the work we do, the jobs we create and the people
behind the innovative solutions we produce. Eligible company
employees can participate in a voluntary, nonpartisan political
action committee called the Celanese Political Action Committee
(“CELPAC”). CELPAC supports candidates for federal, state and local
office in the U.S., representing both major U.S. political parties,
that advocate and pursue government policies that promote the
Company’s interests. CELPAC is governed by a Board of Directors who
regularly evaluates the merits of donations to candidates to align
those donations with the Company’s goals. For our full political
engagement policy and for a list of political contributions, please
go to
https://www.celanese.com/legal/political-engagement-policy/.
Code of Conduct
The Company has adopted a code of business conduct applicable to
directors, executive officers and all other employees. Our
employees, suppliers and customers can ask questions about our code
of conduct and other ethics and compliance issues, or report
potential violations, through Navex, a global Internet and
telephone information and reporting services company. The code of
conduct is available on our compliance website,
http://compliance.celanese.com, by clicking “Business Conduct
Policy”. In the event the Company amends or waives any of the
provisions of the code of conduct applicable to our directors or
executive officers, the Company intends to disclose these actions
on the Company’s website to the extent required by SEC or NYSE
rules.
No Hedging, No Pledging and Anti-Short Sale Policies
The Company's hedging policy prohibits directors, executive
officers and all employees of the Company and its subsidiaries from
engaging in any transaction, acquiring any financial instrument, or
entering into any derivative contract, directly or indirectly
(including through any designee), that hedges or offsets, or is
designed to hedge or offset, any decrease in the market value of
any securities of the Company, including Common Stock, held
directly or indirectly by any such person. The policy applies to
all securities of the Company held by such a person, including
securities not acquired as compensation. The hedging policy
indicates that prohibited hedging may include put options, call
options, forward sale contracts, prepaid variable forward
contracts, equity swaps, collars and exchange funds.
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
38
|
The Company's pledging policy prohibits directors and executive
officers from pledging Common Stock, including holding Common Stock
in a margin account. Directors and executive officers are also
prohibited from engaging in short sales related to Common
Stock.
Director Compensation
Director Compensation Process
Our director compensation program is intended to enhance our
ability to attract, retain and motivate non-employee directors of
exceptional ability and to promote the common interest of directors
and shareholders in enhancing the value of our Common
Stock.
The Board reviews director compensation at least annually based on
recommendations by the NCG Committee. The NCG Committee has the
sole authority to engage a consulting firm to evaluate director
compensation and since 2017 has engaged WTW to assist in setting
director compensation. The NCG Committee reviews director
compensation taking into account multiple factors, including pay
practices and trends at publicly traded companies (including
companies in our compensation peer group and surveys of S&P 500
compensation data), continued expansion of director, committee
chair and lead director responsibilities, and the growing time
commitment of Board and Committee service. The NCG Committee and
the Board base their determinations on director compensation on
recommendations from WTW and these factors. The Board determined
not to make any changes to the level or mix of director
compensation during 2022.
Director Compensation in 2022
The Company uses both cash and equity-based compensation to attract
and retain qualified directors to serve on our Board of Directors,
as follows:
|
|
|
|
|
|
Director Compensation Component |
Amount |
Annual Awards |
Annual cash retainer (paid quarterly)
|
$115,000 |
Annual time-based restricted stock units (“RSU”)(one-year
vesting)
|
$160,000 |
Incremental Awards for Board Leadership |
Annual cash fee for chair: (i) Nominating and Corporate Governance
Committee, and (ii) Environmental, Health, Safety, Quality and
Public Policy Committee
|
$15,000 |
Annual cash fee for chair: (i) Audit Committee, and (ii)
Compensation and Management Development Committee
|
$20,000 |
Annual cash fee for Lead Independent Director
|
$30,000 |
Newly-elected directors receive a pro-rata equity award for a
partial year of service. In addition to the above, Directors are
reimbursed for expenses incurred in attending board, committee and
shareholder meetings. Directors are also reimbursed for reasonable
expenses associated with other business activities that benefit the
Company, including participation in director education programs. We
generally do not provide perquisites to our directors, other than
small gifts provided at Board meetings and upon retirement.
Occasionally, a director may use Company-provided aircraft for
travel to Board meetings.
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
39
|
U.S. non-management directors are entitled to participate in the
Company’s 2008 Deferred Compensation Plan (“2008 Deferred Plan”),
which is an unfunded, nonqualified deferred compensation plan that
allows directors the opportunity to defer all or a portion of their
cash compensation and RSUs in exchange for a future payment amount
equal to their deferments plus or minus certain amounts (including
dividend equivalents) based on the market performance of specified
measurement funds selected by the participant. Deferrals by
directors under the 2008 Deferred Plan, including deferrals of
RSUs, do not receive above-market earnings. Directors Blackwell,
Brown, Galante, Hill, Ihlenfeld, Kissire and Rucker were the only
directors that made contributions to, or had balances in, this plan
during 2022.
2022 Director Compensation Table
The table below is a summary of compensation earned and RSUs
granted by the Company to non-management directors for the fiscal
year ended December 31, 2022.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name(1)
(a)
|
|
Fees
Earned or
Paid in
Cash
($)(2)
(b)
|
|
Stock
Awards
($)(3)
(c)
|
|
Option
Awards($)
(d)
|
|
Non-Equity
Incentive Plan
Compensation
($)
(e) |
|
Change in
Pension
Value and
Nonqualified
Deferred
Compensation
Earnings
($)
(f)
|
|
All Other
Compensation
($)
(g)
|
|
Total
($)
(h) |
Jean S. Blackwell |
|
115,000 |
|
|
159,957 |
|
|
— |
|
— |
|
— |
|
— |
|
274,957 |
|
William M. Brown |
|
145,000 |
|
|
159,957 |
|
|
— |
|
— |
|
— |
|
— |
|
304,957 |
|
Edward G. Galante |
|
135,000 |
|
|
159,957 |
|
|
— |
|
— |
|
— |
|
— |
|
294,957 |
|
Rahul Ghai |
|
86,250 |
|
|
199,873 |
|
|
— |
|
— |
|
— |
|
— |
|
286,123 |
|
Kathryn M. Hill |
|
130,000 |
|
|
159,957 |
|
|
— |
|
— |
|
— |
|
— |
|
289,957 |
|
David F. Hoffmeister |
|
115,000 |
|
|
159,957 |
|
|
— |
|
— |
|
— |
|
— |
|
274,957 |
|
Dr. Jay V. Ihlenfeld |
|
115,000 |
|
|
159,957 |
|
|
— |
|
— |
|
— |
|
— |
|
274,957 |
|
Deborah J. Kissire |
|
135,000 |
|
|
159,957 |
|
|
— |
|
— |
|
— |
|
— |
|
294,957 |
|
Michael Koenig |
|
86,250 |
|
|
199,873 |
|
|
— |
|
— |
|
— |
|
— |
|
286,123 |
|
Kim K.W. Rucker |
|
130,000 |
|
|
159,957 |
|
|
— |
|
— |
|
— |
|
— |
|
289,957 |
|
(1)Ms.
Ryerkerk is not included in this table because she was an employee
of the Company during 2022 and received no compensation for her
services as a director.
(2)Includes
amounts earned for the annual retainer and committee chair and lead
independent director fees for the respective independent directors,
as applicable.
(3)Represents
the grant date fair value of 1,098 RSUs granted to each
non-management director (1,372 RSUs for each of Mr. Ghai and Mr.
Koenig, which included a prorated amount of RSUs for time served
from their February 2022 election through April 2022) in April 2022
under the 2018 Global Incentive Plan. The fair value of RSUs
granted to our non-management directors under our 2022 LTIP as part
of the annual award was calculated to be $145.68 per RSU, which
reflects the average of the high and low market price of our Common
Stock as reported by the NYSE on the applicable grant date
discounted for lack of dividend participation. As of
December 31, 2022, each non-management director listed in the
table owned 1,098 RSUs, except Mr. Ghai and Mr. Koenig who each
held 1,372 RSUs.
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
40
|
Director Stock Ownership Guidelines
The Board of Directors considers Common Stock ownership by
directors to be of utmost importance. The Board believes such
ownership enhances the commitment of directors to our future and
aligns their interests with those of our other shareholders. The
Board has therefore established minimum stock ownership guidelines
for non-employee directors that require each director to own Common
Stock having a value of at least five times his or her base annual
cash retainer of $115,000. Each newly elected director has five
years from the year elected to reach this ownership level. During
the five-year period, a director may not sell more than 50% of the
shares received as compensation. As of the computation date,
December 31, 2022, all of our then current non-employee
directors had attained the minimum stock ownership levels based on
their holdings except for Ms. Kissire, who joined the Board in 2020
and Messrs. Ghai and Koenig who joined the Board in February 2022.
Ms. Kissire and Mr. Koenig are on-track for compliance by their
respective 2025 and 2027 compliance dates.
Director Independence and Related Person Transactions
Director Independence
The listing standards of the NYSE require companies listed on the
NYSE to have a majority of “independent” directors. As noted below,
all of our directors, other than our Chief Executive Officer, are
independent.
The Board of Directors has adopted standards of independence for
directors that are set forth in Exhibit A to the Company’s
corporate governance guidelines. The Board reviews and determines
the independence of each of the directors in accordance with these
standards. The full text of the corporate governance guidelines is
available on our website, https://investors.celanese.com, by
clicking “Corporate Governance”. These standards incorporate all of
the requirements for director independence contained in the NYSE
listing standards. The NYSE listing standards generally provide
that a director is independent if the Board affirmatively
determines that the director has no material relationship with the
Company directly or as a partner, shareholder or officer of an
organization that has a relationship with the Company. In addition,
a director is not independent if certain other relationships
exist.
The Board, based on the recommendation of the NCG Committee,
affirmatively determined that ten of our current directors, Ms.
Blackwell, Mr. Brown, Mr. Galante, Mr. Ghai, Ms. Hill, Mr.
Hoffmeister, Mr. Ihlenfeld, Ms. Kissire, Mr. Koenig, and Ms. Rucker
are independent of the Company and its management under the NYSE
listing standards and the Company’s director independence
standards. Ms. Ryerkerk, our CEO, is the only current director who
is not independent.
In addition, in compliance with the NYSE listing standards, we have
an Audit Committee, a Compensation and Management Development
Committee and a Nominating and Corporate Governance Committee that
are each entirely composed of independent directors. Each of these
committees have written charters addressing the respective
committee’s purpose and responsibilities and the annual evaluation
of the performance of these committees.
The Company in the normal course of business has been a party to
transactions with other entities (or their subsidiaries) where
certain of our directors are themselves either directors or
officers. When making the Board’s director independence
determination, the Board was aware of, and considered, the
relationships listed below. All of the business relationships noted
below were entered into on standard pricing and terms and arose in
the ordinary course of our business. The amounts involved in each
relationship did not exceed, in any of the last three fiscal years:
(1) the greater of $1,000,000 or two percent of either company’s
consolidated gross revenues, in the case of entities where our
directors serve on the board, or (2) 1% of the consolidated gross
revenues of the Company or the director’s entity, in the case of
entities where our directors serve as executive officers. As a
result, each qualified under a categorical standard of independence
that the Board previously approved and none of the
relationships
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
41
|
were otherwise deemed to be a material relationship that impaired
the director’s independence.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Director |
Organization |
Director’s Relationship
to Organization |
Type of Transaction, Relationship or Arrangement |
Does the Amount Exceed the Greater of $1 million or 2% of
either company’s Gross Revenues?(1)
|
Jean S. Blackwell |
Ingevity Corporation and its subsidiaries and
affiliates |
Director |
Business Relationship - Routine sales to Ingevity |
No |
Johnson Controls International plc and its subsidiaries and
affiliates |
Director |
Business Relationship - Routine purchases from Johnson
Controls |
No |
William M. Brown |
Becton, Dickinson and Company and its subsidiaries and
affiliates |
Director |
Business Relationship - Routine sales to Becton,
Dickinson |
No |
Edward G. Galante |
Linde plc and subsidiaries and affiliates |
Director |
Business Relationship - Routine purchases from Linde |
No |
Clean Harbors and its subsidiaries and affiliates |
Director |
Business Relationship - Routine purchases from Clean
Harbors |
No |
Rahul Ghai |
Otis Worldwide Corporation and its subsidiaries and
affiliates |
Chief Financial Officer |
Business Relationship - Routine purchases from Otis |
No |
GE Aviation LLC and its subsidiaries and affiliates |
Chief Financial Officer |
Business Relationship - Routine sales to, and purchases from,
GE |
No |
Kathryn M. Hill |
Moody’s Corporation and its subsidiaries and affiliates |
Director |
Business Relationship - Routine purchases from Moody’s |
No |
David F. Hoffmeister |
Glaukos Corporation and its subsidiaries and affiliates |
Director |
Business Relationship - Routine sales to Glaukos |
No |
Dr. Jay V. Ihlenfeld |
Ashland, Inc. and its subsidiaries and affiliates |
Director |
Business Relationship - Routine sales to, and purchases from,
Ashland |
No |
Deborah J. Kissire |
Axalta Coating Systems Ltd. and its subsidiaries and
affiliates |
Director |
Business Relationship - Routine sales to Axalta |
No |
Michael Koenig |
Nobian Industrial Chemicals B.V. and its subsidiaries and
affiliates |
Chief Executive Officer |
Business Relationship - Routine purchases from Nobian |
No |
Symrise AG and its subsidiaries and affiliates |
Director |
Business Relationship - Routine sales to Symrise |
No |
Kim K.W. Rucker |
HP Inc. and its subsidiaries and affiliates |
Director |
Business Relationship - Routine purchases from HP |
No |
Lori J. Ryerkerk |
Eaton Corporation Plc and its subsidiaries and
affiliates |
Director |
Business Relationship - Routine sales to, and purchases from,
Eaton |
No |
(1)
In cases where our Board member serves as an executive officer,
such transactions did not exceed 1% of either company’s gross
revenues.
There are no family relationships among our directors or executive
officers.
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
42
|
Certain Relationships
and Related Person Transactions
The Board of Directors has adopted a written policy regarding
related person transactions (the “Related Party Transaction
Policy”). For purposes of SEC rules and such policy, an interested
transaction is a transaction or relationship in which the aggregate
amount involved exceeds or may reasonably be expected to exceed
$120,000 since the beginning of the Company’s last fiscal year, the
Company or any of its subsidiaries is a participant, and any
related party will have a direct or indirect material interest in
the transaction or relationship. A related party is any person who
is or was during the last fiscal year an executive officer,
director or nominee for election as a director; a greater than
5 percent beneficial owner of Common Stock; or an immediate
family member of any of these persons. Compensation paid to our
named executive officers is not treated as an interested
transaction under the Related Party Transaction Policy to the
extent that it is disclosed as compensation in this Proxy
Statement. In addition, a related party would not be deemed to have
a “material interest” in a transaction simply due to such person’s
position as a director of the other party in the transaction or, in
the case of simply being an employee of the other party to the
transaction, in the latter case if the aggregate amount involved in
the subject year does not exceed the greater of $1,000,000 or two
percent of that party’s annual revenues.
The Audit Committee reviews the material facts of all interested
transactions that meet the requirements discussed above and
therefore require the Audit Committee’s approval and either
approves or disapproves of the entry into the interested
transaction. In determining whether to approve an interested
transaction, the Audit Committee takes into account, among other
factors it deems appropriate, whether the interested transaction is
on terms no less favorable than terms generally available to an
unaffiliated third-party under the same or similar circumstances
and the extent of the related party’s interest in the transaction.
The Audit Committee may not approve any interested transaction if
it determines the interested transaction to be inconsistent with
the interests of the Company and the shareholders.
In addition, the Audit Committee has delegated to the chair of the
Audit Committee the authority to approve any interested transaction
with a related party (other than the chair or an immediate family
member of the chair) in which the aggregate amount involved is
expected to be less than $2,000,000. In connection with regularly
scheduled meetings of the Audit Committee, the Company provides the
Audit Committee for its review, a summary of each new interested
transaction that was approved by the chair of the Audit Committee.
No director may participate in any discussion or approval of an
interested transaction for which he or she is a related party,
except that the director is required to provide all material
information concerning the interested transaction to the Audit
Committee.
No interested transactions were approved or ratified or, to our
knowledge, required to be approved or ratified, during
2022.
None of our directors are adverse to the Company in any pending
litigation or proceeding.
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
43
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Ownership Information |
|
STOCK OWNERSHIP INFORMATION
Principal Shareholders and Beneficial Owners
The following table sets forth information with respect to the
beneficial ownership of Common Stock as of February 22, 2023,
by (i) each person known to the Company to beneficially own
more than 5% of our Common Stock; (ii) each of the Company’s
present directors, including those nominated for election at the
Annual Meeting; (iii) the Company’s named executive officers ;
and (iv) all present directors and executive officers of the
Company as a group. The percentage of beneficial ownership set
forth below is calculated in accordance with SEC Rules and is based
on the number of shares of Common Stock outstanding and entitled to
vote as of February 22, 2023, which was
110,824,914.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount and Nature of Beneficial Ownership of Common
Stock |
|
|
Common Stock
Beneficially Owned(1)
|
|
Rights to
Acquire
Shares of Common Stock(2)
|
|
Total
Common
Stock
Beneficially Owned |
|
Percentage of
Common Stock
Beneficially Owned |
|
|
|
|
|
The Vanguard Group, Inc.(3)
|
|
13,332,489 |
|
|
— |
|
|
13,332,489 |
|
|
12.0 |
|
Berkshire Hathaway(4)
|
|
9,710,183 |
|
|
— |
|
|
9,710,183 |
|
|
8.8 |
|
BlackRock, Inc.(5)
|
|
7,642,363 |
|
|
— |
|
|
7,642,363 |
|
|
6.9 |
|
Dodge & Cox(6)
|
|
7,109,524 |
|
|
— |
|
|
7,109,524 |
|
|
6.4 |
|
Wellington Management Company, LLP(7)
|
|
6,479,930 |
|
|
— |
|
|
6,479,930 |
|
|
5.8 |
|
Directors(8)(9)
|
|
|
|
|
|
|
|
|
Jean S. Blackwell |
|
8,201 |
|
|
— |
|
|
8,201 |
|
|
* |
William M. Brown |
|
103 |
|
|
— |
|
|
103 |
|
|
* |
Edward G. Galante |
|
10,898 |
|
|
— |
|
|
10,898 |
|
|
* |
Rahul Ghai |
|
— |
|
|
— |
|
|
— |
|
|
* |
Kathryn M. Hill |
|
9,474 |
|
|
— |
|
|
9,474 |
|
|
* |
David F. Hoffmeister |
|
47,395 |
|
|
— |
|
|
47,395 |
|
|
* |
Dr. Jay V. Ihlenfeld |
|
8,485 |
|
|
— |
|
|
8,485 |
|
|
* |
Deborah J. Kissire |
|
100 |
|
|
|
|
100 |
|
|
* |
Michael Koenig |
|
— |
|
|
— |
|
|
— |
|
|
* |
Kim K.W. Rucker |
|
56 |
|
|
— |
|
|
56 |
|
|
* |
Named Executive Officers(8)
|
|
|
|
|
|
|
|
|
John G. Fotheringham |
|
27,107 |
|
|
— |
|
|
27,107 |
|
|
* |
Thomas F. Kelly |
|
42,709 |
|
|
— |
|
|
42,709 |
|
|
* |
A. Lynne Puckett |
|
35,725 |
|
|
— |
|
|
35,725 |
|
|
* |
Scott A. Richardson |
|
63,112 |
|
(9)
|
— |
|
|
63,112 |
|
|
* |
Lori J. Ryerkerk(10)
|
|
105,425 |
|
|
— |
|
|
105,425 |
|
|
* |
All present directors, nominees and executive officers as a group
(16 persons)(11)
|
|
361,482 |
|
|
— |
|
|
361,482 |
|
|
* |
*Less
than 1% of shares.
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
44
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Ownership Information |
|
(1)Includes
shares for which the named person or entity has sole and/or shared
voting and/or investment power. Does not include shares that may be
acquired through the vesting of restricted stock units or other
rights to acquire shares. To our knowledge, none of the Common
Stock listed as beneficially owned by the current directors or
executive officers are subject to hedges or have been
pledged.
(2)Reflects
rights to acquire shares of Common Stock within 60 days of
February 22, 2023, and includes, as applicable, shares of
Common Stock issuable upon the vesting of restricted stock
units granted under the 2018 GIP within 60 days of
February 22, 2023. Does not include units in a stock
denominated deferred compensation plan with investments settled in
shares of Common Stock as follows: Ms. Blackwell – 8,822 equivalent
shares, Mr. Brown – 11,209 equivalent shares, Mr. Galante – 6,467
equivalent shares, Ms. Hill 988 equivalent shares, Dr. Ihlenfeld –
9,730 equivalent shares, Ms. Kissire – 1,765 equivalent shares, and
Ms. Rucker – 5,181 equivalent shares.
(3)On
February 9, 2023, The Vanguard Group, Inc. (“Vanguard Group”) filed
Amendment No. 9 to Schedule 13G with the SEC reporting beneficial
ownership of 13,332,489 shares of Common Stock as of December
30, 2022, with shared voting power over 144,720 shares, sole
dispositive power over 12,918,891 shares and shared dispositive
power over 413,598 shares. The address of Vanguard Group is 100
Vanguard Blvd., Malvern, PA 19355.
(4)On
February 14, 2023, Berkshire Hathaway filed a Schedule 13G with the
SEC reporting beneficial ownership as of December 31, 2022.
According to the Schedule 13 filing, (i) Warren E. Buffett and
Berkshire Hathaway Inc. have shared voting power over
9,710,183 shares and shared dispositive power over
9,710,183 shares and (ii) National Indemnity Company has
shared voting power over 8,487,966 shares and shared dispositive
power over 8,487,966 shares. Information about other entities
deemed to share beneficial ownership of the shares, including their
voting and dispositive power, is disclosed in the Schedule 13G. The
address of Berkshire Hathaway is 3555 Farnam Street, Omaha, NE
68131.
(5)On
January 31, 2023, BlackRock, Inc. (“BlackRock”) filed a Schedule
13G with the SEC reporting beneficial ownership of
7,642,363 shares of Common Stock as of December 31, 2022, with
sole voting power over 6,826,709 shares and sole dispositive power
over 7,642,363 shares. The address of BlackRock is 55 East 52nd
Street, New York, NY 10055.
(6)On
February 14, 2023, Dodge & Cox filed Amendment No. 13 to
Schedule 13G with the SEC reporting beneficial ownership of
7,109,524 shares of Common Stock as of December 31, 2022, with
sole voting power over 6,694,537 shares and sole dispositive power
over 7,109,524 shares. The address of Dodge & Cox is 555
California Street, 40th Floor, San Francisco, CA
94104.
(7)On
February 6, 2023, Wellington Group Holdings LLP (“Wellington”)
filed Amendment No. 3 to Schedule 13G with the SEC reporting
beneficial ownership of 6,961,945 shares of Common Stock as of
December 30, 2022, with shared voting power over 6,501,658 shares
and shared dispositive power over 6,961,945 shares. The address of
Wellington is 280 Congress Street, Boston, MA 02210.
(8)Listed
alphabetically. To our knowledge and subject to applicable
community property rules, each person has sole investment and
voting power with respect to the Common Stock beneficially owned by
such person.
(9)Includes
beneficial ownership of Common Stock by Mr. Richardson of 572
equivalent shares in the Celanese Stock Fund under the CARSP as of
February 22, 2023. Mr. Richardson has the ability to direct
the voting of the Common Stock underlying these equivalent shares
and the ability to change their investment options at any
time.
(10)Ms.
Ryerkerk also serves as a director and her ownership information is
set forth under “Named Executive Officers.”
(11)Does
not include an estimated 123,425 PRSUs (at target) held as of
February 22, 2023 by our named executive officers and other
executive officers, which are subject to future performance and
vesting conditions and therefore does not represent rights to
acquire shares of Common Stock within 60 days of February 22,
2023.
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
45
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Ownership Information |
|
Securities Authorized for Issuance Under Equity Compensation
Plans
The following information is provided as of December 31, 2022 with
respect to equity compensation plans:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Plan Category |
|
Number of Securities to be Issued upon Exercise of Outstanding
Options, Warrants and Rights |
|
Weighted Average Exercise Price of Outstanding Options, Warrants
and Rights |
|
Number of Securities Remaining Available for Future Issuance Under
Equity Compensation Plans (excluding securities reflected in column
(a)) |
|
|
|
(a) |
|
(b) |
|
(c) |
|
Equity compensation plans approved by security holders |
|
1,233,281 |
|
(1)
|
$ |
— |
|
(2)
|
16,292,213 |
|
(3)
|
Equity compensation plans not approved by security
holders |
|
— |
|
|
$ |
— |
|
|
— |
|
|
Total |
|
1,233,281 |
|
|
$ |
— |
|
|
16,292,213 |
|
|
(1)Includes
1,233,281 restricted stock units ("RSUs") granted under the
Celanese Corporation 2018 Global Incentive Plan (the "2018 Plan"),
including shares that may be issued pursuant to outstanding
performance-based RSUs, assuming currently estimated maximum
potential performance; actual shares issued may vary, depending on
actual performance. If the performance-based RSUs included in this
total vest at the target performance level (as opposed to the
maximum potential performance), the aggregate RSUs outstanding
would be 831,766. Also includes 41,365 share equivalents
attributable to RSUs deferred by non-management directors under the
Company's 2008 Deferred Compensation Plan (and dividends applied to
previous deferrals) and distributable in the form of shares of
Common Stock under the 2018 Plan. Upon vesting, a share of the
Company's Common Stock is issued for each RSU. Column (b) does not
take any of these RSU awards into account because they do not have
an exercise price.
(2)There
were no outstanding options under the 2018 Plan as of December 31,
2022.
(3)Includes
shares available for future issuance under the 2018 Plan and the
Celanese Corporation 2009 Employee Stock Purchase Plan approved by
shareholders on April 23, 2009 (the "ESPP"). As of December 31,
2022, an aggregate of 2,786,536 shares were available for future
issuance under the 2018 Plan and 13,505,677 shares of our Common
Stock were available for future issuance under the ESPP. As of
December 31, 2022, 494,323 shares have been offered for
purchase under the ESPP.
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
46
|
AUDIT MATTERS
Audit Committee Report
The Audit Committee is composed of five independent directors, each
of whom satisfies the independence requirement of Rule 10A-3 under
the Securities Exchange Act of 1934, as amended. The Audit
Committee assists the Board of Directors in fulfilling its
oversight responsibilities with respect to the external reporting
process and the Company’s internal controls. The Audit Committee
serves as the primary communication link among the Board, the
independent public accounting firm, and our internal
auditors.
Company management is responsible for the financial statements and
the reporting process, including the system of disclosure controls
and procedures and the internal control over financial reporting.
The independent registered public accounting firm, KPMG LLP, is
responsible for performing an independent audit of the Company’s
consolidated financial statements and expressing an opinion on the
conformity of the audited financial statements with accounting
principles generally accepted in the United States and on the
effectiveness of the Company’s internal control over financial
reporting.
The Audit Committee reviewed and discussed with the Company’s
management and KPMG LLP the audited financial statements for the
Company for the year ended December 31, 2022. The Audit
Committee also met with KPMG LLP and the internal auditors, with
and without management present, to discuss the results of the
auditors’ examinations, their evaluation of our internal control,
and the overall quality of our financial reporting. The Audit
Committee also discussed with KPMG LLP the matters required to be
discussed by the applicable requirements of the Public Company
Accounting Oversight Board (the “PCAOB”) and the SEC. In addition,
the Audit Committee reviewed and discussed with KPMG LLP its
independence from the Company and management, including the matters
in the written disclosures received by the Audit Committee and
required by PCAOB rules.
The Audit Committee discussed with KPMG LLP and the internal
auditors the overall scope and plans for their respective audits.
The Audit Committee reviewed and discussed the fees billed to the
Company by KPMG LLP for audit, audit-related, tax and other
services provided during fiscal 2022, which are set forth
under
“Item
2: Ratification of Independent Registered Public Accounting
Firm”,
and determined that the provision of non-audit services is
compatible with KPMG LLP’s independence. Based on the Audit
Committee’s reviews and discussions described above, the Audit
Committee recommended to the Board of Directors that the audited
consolidated financial statements for the Company be included in
the Company’s Annual Report on Form 10-K for the year ended
December 31, 2022 for filing with the SEC.
The Audit Committee evaluates the performance of the independent
registered public accounting firm each year and determines whether
to re-engage the current firm or consider other audit firms. In
doing so, the Audit Committee considers the quality and efficiency
of the services provided by the registered public accounting firm,
along with their capabilities, technical expertise, and knowledge
of our operations and industry. Based on these evaluations, the
Audit Committee decided to engage KPMG LLP as our independent
registered public accounting firm for fiscal 2023. Although the
Audit Committee has the sole authority to appoint the independent
registered public accounting firm, the Audit Committee has
continued its long-standing practice of recommending that the Board
ask our shareholders to ratify the appointment of the registered
public accounting firm at our annual meeting of shareholders. This
report was submitted by the current members of the Audit
Committee,
|
|
|
|
|
|
|
|
|
|
|
|
Dated: February 21, 2023 |
Deborah J. Kissire, Chair |
|
(The Audit Committee report does not constitute soliciting
material, and shall not be deemed to be filed or incorporated by
reference into any other filing under the Securities Act of 1933,
or the Securities Exchange Act of 1934, except to the extent that
the Company specifically incorporates the Audit Committee report by
reference therein.)
|
|
Jean S. Blackwell |
|
|
Rahul Ghai |
|
|
David F. Hoffmeister |
|
|
Kim K.W. Rucker |
|
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
47
|
ITEM 2:
Ratification of Appointment of Independent Registered Public
Accounting Firm
The Audit Committee of the Board of Directors has selected KPMG LLP
to audit the Company’s consolidated financial statements for the
fiscal year ending December 31, 2023. Since 2004, KPMG LLP has
served as our independent registered public accounting firm and
also provided other audit-related and non-audit services that were
approved by the Audit Committee.
Representatives of KPMG LLP will virtually attend the Annual
Meeting, will have the opportunity to make a statement if they
desire and will be available to respond to appropriate questions
from shareholders.
We are asking our shareholders to ratify the selection of KPMG LLP
as our independent registered public accounting firm. Although
ratification is not required by our by-laws or otherwise, the Board
is submitting the Audit Committee’s selection of KPMG LLP to our
shareholders for ratification as a matter of good corporate
practice. Even if the selection is ratified, the Audit Committee in
its discretion may select a different registered public accounting
firm at any time during the year if it determines that such a
change would be in the best interests of the Company and our
shareholders. If the appointment of KPMG LLP is not ratified, the
Audit Committee will evaluate the basis for the shareholders’ vote
when determining whether to continue the firm’s
engagement.
Audit and Related Fees
Aggregate fees billed to the Company by KPMG LLP and its affiliates
were as follows:
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
2022 |
2021 |
|
Audit Fees(1)
|
$ |
9,862,406 |
|
$ |
7,786,275 |
|
|
Audit-related Fees(2)
|
$ |
9,000 |
|
$ |
60,028 |
|
|
Tax Fees(3)
|
$ |
1,378,409 |
|
$ |
1,321,559 |
|
|
All Other Fees(4)
|
$ |
15,000 |
|
— |
|
|
Total Fees |
$ |
11,264,815 |
|
$ |
9,167,862 |
|
|
(1)For
professional services rendered for the audits of annual
consolidated financial statements of the Company (including the
audit of internal control over financial reporting), statutory
audits in non-U.S. jurisdictions, the review of the Company’s
quarterly consolidated financial statements and review of SEC
filings.
(2)Primarily
for professional services rendered in connection with consultation
on financial accounting and reporting standards and employee
benefit plan audits.
(3)Primarily
for professional services related to technical assistance, the
preparation of tax returns in non-U.S. jurisdictions and assistance
with tax audits and appeals.
(4)For
other permitted professional advisory services.
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
48
|
Audit Committee Pre-Approval
Policy
The Audit Committee is responsible for appointing, retaining and
pre-approving the fees of the Company’s independent registered
public accounting firm. The Audit Committee has adopted a Policy
for Pre-Approval of Independent Auditor Services (“Pre-Approval
Policy”) pursuant to which proposed services may be pre-approved
through the application of detailed policies and procedures
(“general pre-approval”) or by specific review of each service
(“specific pre-approval”). The Audit Committee has provided general
pre-approval for certain specific types of non-prohibited audit,
audit-related and tax services that do not exceed $200,000 per
project and $1,000,000 per year in the aggregate and gives detailed
guidance to management as to the specific services that are
eligible for general pre-approval. The Audit Committee is to be
informed on a timely basis of any services performed by the
independent registered public accounting firm pursuant to general
pre-approval. Unless a type of service is included in this general
pre-approval, it will require specific pre-approval. The annual
audit services engagement terms and fees must be specifically
pre-approved by the Audit Committee. Requests to provide services
that require specific pre-approval must be submitted to the Audit
Committee by both the independent registered public accounting firm
and the chief financial officer or corporate controller, and must
include detailed back-up documentation and a joint statement as to
whether the request or application is consistent with the SEC’s
rule on auditor independence.
The Audit Committee may delegate its pre-approval authority to one
or more of its members. The member or members to whom such
authority is delegated must report any pre-approval decisions to
the Audit Committee at its next scheduled meeting.
All services performed by our independent registered public
accounting firm in 2022 were pre-approved by the Audit Committee or
otherwise under the Pre-Approval Policy.
Vote Required
Although ratification is not required in our by-laws or otherwise,
approval of this proposal requires the affirmative vote of a
majority of the shares of Common Stock present in person or
represented by proxy and entitled to vote.
Recommendation of the Board
THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT SHAREHOLDERS
VOTE
“FOR” THE RATIFICATION OF KPMG LLP AS OUR INDEPENDENT
REGISTERED
PUBLIC ACCOUNTING FIRM FOR 2023
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
49
|
EXECUTIVE COMPENSATION
Table of Contents
|
|
|
|
|
|
ITEM 3:
ADVISORY APPROVAL OF EXECUTIVE COMPENSATION
|
|
|
|
ITEM 4:
ADVISORY APPROVAL OF SAY ON PAY VOTE FREQUENCY
|
|
|
|
COMPENSATION DISCUSSION AND ANALYSIS |
|
CD&A Highlights |
|
Named Executive Officers |
|
We Follow Compensation Governance Best Practices |
|
|
|
Human Capital Management |
|
|
|
|
|
2022 Say on Pay Vote and Shareholder Engagement
|
|
Compensation Philosophy and Elements of Pay |
|
Compensation Philosophy |
|
Compensation Objectives |
|
Elements of Compensation |
|
Setting Total Compensation |
|
Our Use of Peer Groups |
|
Compensation Decisions |
|
Base Salary |
|
Annual Incentive Plan Awards |
|
Long-Term Incentive Compensation |
|
Compensation Governance |
|
Compensation and Management Development Committee
Oversight |
|
|
|
|
|
|
|
|
|
Role of the CMDC’s Independent Compensation Consultant |
|
Role of Management and Management’s Consultant |
|
Additional Information Regarding Executive Compensation |
|
Other Compensation Elements |
|
Executive Stock Ownership Requirements |
|
Executive Compensation Clawback Policy |
|
Tax and Accounting Considerations |
|
|
|
COMPENSATION RISK ASSESSMENT |
|
|
|
COMPENSATION AND MANAGEMENT DEVELOPMENT COMMITTEE
REPORT |
|
|
|
COMPENSATION TABLES |
|
2022 Summary Compensation Table
|
|
2022 Grants of Plan-Based Awards Table
|
|
Outstanding Equity Awards at Fiscal 2022 Year-End
Table
|
|
2022 Option Exercises and Stock Vested Table
|
|
2022 Pension Benefits Table
|
|
2022 Nonqualified Deferred Compensation Table
|
|
Potential Payments Upon Termination or Change in
Control |
|
|
|
CEO PAY RATIO |
|
PAY VERSUS PERFORMANCE |
|
Non-GAAP Financial Measures
This Proxy Statement, including the Compensation Discussion and
Analysis, contains financial measures presented on a non-GAAP
basis. Celanese’s non-GAAP financial measures used in this document
are as follows: [1] Adjusted earnings per share (or Adjusted EPS),
which we define as earnings (loss) from continuing operations
attributable to Celanese Corporation, adjusted for income tax
(provision) benefit, Certain Items, and refinancing and related
expenses, divided by the number of basic common shares and dilutive
restricted stock units and stock options calculated using the
treasury method; [2] Free cash flow, which we define as net cash
provided by (used in) operations, less capital expenditures on
property, plant and equipment, and adjusted for capital
contributions from or distributions to our partner in our methanol
joint venture; [3] Adjusted EBIT, which we define as net earnings
(loss) attributable to Celanese Corporation, plus (earnings) loss
from discontinued operations, less interest income, plus interest
expense, plus refinancing expense and taxes, and further adjusted
for Certain Items; and [4] Return on invested capital (adjusted),
which we define as Adjusted EBIT, tax effected using the adjusted
tax rate, divided by the sum of the average of beginning and ending
short- and long-term debt and Celanese Corporation shareholders’
equity. See “Exhibit A”
to this Proxy Statement for additional information concerning these
performance measures and a reconciliation of these measures to
earnings (loss) from continuing operations attributable to Celanese
Corporation per common share-diluted, net cash provided by (used
in) operations, net earnings (loss) attributable to Celanese
Corporation, and net earnings (loss) attributable to Celanese
Corporation divided by the sum of the average of beginning and end
the of year short- and long-term debt and Celanese Corporation
shareholders’ equity, the most comparable U.S. GAAP financial
measures, respectively.
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
50
|
ITEM 3:
Advisory Approval of Executive Compensation
The Company’s compensation program for our named executive officers
(“NEOs”) was designed by our compensation and management
development committee (the “CMDC”) to meet our compensation
philosophy and objectives, including maintaining a pay for
performance culture. The principles of the program have contributed
to our strong performance. See
“CD&A
Highlights”
for a summary of our compensation structure, 2022 performance, pay
decisions and approach to compensation oversight.
This “say-on-pay” proposal gives shareholders the opportunity
annually to cast a vote on our executive compensation program based
on the following resolution:
“Resolved, that the shareholders approve, on an advisory basis, the
compensation of our NEOs, as disclosed pursuant to Item 402 of
Regulation S-K, including the Compensation Discussion and
Analysis, compensation tables and narrative disclosure, contained
in this Proxy Statement.”
The Board of Directors recommends that shareholders endorse the
compensation program for our NEOs by voting FOR the above
resolution. Our compensation program is the result of a carefully
considered approach and takes into account input provided by
shareholders and advice received from the CMDC’s independent
compensation consultant. We believe that executive compensation for
2022 was supported by our performance. The Board of Directors
currently has a policy of holding annual advisory votes to approve
our executive compensation. Provided that the Board of Directors
does not modify this policy, including after consideration of the
results of Item 4, the Company’s next say-on-pay proposal after the
2023 Annual Meeting will be presented at the 2024 Annual Meeting of
Shareholders.
Advisory Vote
This vote is mandated by Section 951 of the Dodd-Frank Wall
Street Reform and Consumer Protection Act and SEC regulations. As
an advisory vote, this proposal is not binding upon the Company. In
addition, the non-binding advisory vote described in this proposal
will not be construed as overruling any decision by the Company,
the Board of Directors, or the CMDC, relating to the compensation
of the NEOs, or creating or changing any fiduciary duties or
other duties on the part of the Board of Directors, or any
committee of the Board of Directors, or the Company.
Vote Required
Approval of this proposal requires the affirmative vote of a
majority of the shares of Common Stock present in person or
represented by proxy and entitled to vote.
Recommendation of the Board
THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT
SHAREHOLDERS
VOTE “FOR” THE APPROVAL OF OUR EXECUTIVE COMPENSATION
PROGRAM
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
51
|
ITEM 4:
Advisory Approval of Say on Pay Vote Frequency
In addition to providing an advisory vote on our executive
compensation program, we are requesting that shareholders indicate
their preference for the frequency with which future advisory votes
on executive compensation should take place – every one, two or
three years. This vote is mandated at least every six years by
Section 951 of the Dodd-Frank Wall Street Reform and Consumer
Protection Act and SEC regulations. At our 2017 Annual Meeting,
during which the Company held its most recent say-on--frequency
vote, shareholders indicated their preference for annual advisory
voting on our executive compensation plan.
Shareholders may indicate their preference on this advisory vote by
choosing every year, every other year, or every three years, or
abstaining on this vote, when shareholders vote in response to the
resolution set forth below. We will ask shareholders not less than
every six years whether they desire a different vote frequency on
the advisory vote on executive compensation.
“Resolved, that a non-binding advisory vote of the Company’s
shareholders to approve, on an advisory basis, the compensation of
our named executive officers, as disclosed pursuant to Item 402 of
Regulation S-K, including the Compensation Discussion and Analysis,
compensation tables and narrative disclosure, in the proxy
statement of the Company for the annual meeting of shareholders of
the Company at which such advisory vote is to occur, be held every
year, every other year or every three years, or
abstain.”
The Board of Directors has recommended that shareholders approve
that we conduct an advisory vote on executive compensation
annually. We believe that an annual review of our executive
compensation practices will be better aligned with shareholders’
interests as it allows us to obtain information on shareholders’
views of the compensation of our named executive officers on a more
consistent basis. It also allows us to engage in regular dialogue
with our shareholders on corporate governance matters, including
our executive compensation philosophy, policies and programs. For
these reasons, we believe that shareholders should support an
annual advisory vote on executive compensation.
Advisory Vote
The option that receives the highest number of votes cast by the
shareholders will be the frequency for the advisory vote on NEO
compensation that has been selected by shareholders. However,
because this is an advisory vote, this proposal is not binding upon
the Company in any way and the CMDC and the Board of Directors may
decide that it is in the best interests of shareholders and the
Company to hold an advisory vote to approve executive compensation
more or less frequently than the option approved by the
shareholders. The CMDC and the Board of Directors highly value the
opinions expressed by shareholders in their vote on this proposal,
and will consider the outcome of the vote when making a decision
about the frequency of future advisory votes on executive
compensation.
Vote Required
The option that receives the highest number of votes cast by
shareholders will be the advisory vote frequency selected by
shareholders. However, as noted above, the voting on this proposal
is advisory. Not later than 2029, we will have another vote to
determine the frequency of this advisory vote.
Recommendation of the Board
THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THE SELECTION OF “ONE
YEAR” AS THE
SHAREHOLDERS’ PREFERENCE FOR THE FREQUENCY WITH WHICH SHAREHOLDERS
ARE PROVIDED AN
ADVISORY VOTE ON OUR EXECUTIVE COMPENSATION PROGRAM
|
|
|
|
|
|
|
|
|
|
Celanese 2023 / Notice of Annual Meeting and Proxy Statement /
52
|
Compensation Discussion and Analysis
Our Compensation Discussion and Analysis describes the objectives
and elements of our executive compensation program, its alignment
with performance and 2022 compensation decisions regarding our
NEOs.
CD&A Highlights